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ABSTRACT 
David William Wyatt: Essential Roles for Polymerase Theta-Mediated End Joining in 
Repair of Chromosome Breaks 
(Under the direction of Dale Ramsden) 
 
 DNA double strand breaks (DSBs) constitute a rare but lethal class of genomic 
damage that must be efficiently repaired. Deficiencies in DSB repair pathways manifest 
themselves as severe phenotypes including cancer predisposition, accelerated aging, 
and immunodeficiency. On the cellular level, failure to repair DSBs can result in 
genomic abnormalities, chromosomal rearrangements, and apoptosis. In mammalian 
cells, repair of DSBs proceeds by classical nonhomologous end joining (NHEJ), 
homologous recombination (HR), or by a third loosely described non-canonical repair 
pathway, termed alternative end joining (Alt-EJ). Amongst the most clearly defined 
characteristics of Alt-EJ is the presence microhomology, or small patches of 
complementary DNA sequence flanking a chromosome break, in the repair junction.    
DNA Polymerase Theta (Pol q) has been implicated as a primary mediator of this 
alternative repair pathway, but its cellular mechanism and role relative to canonical 
repair pathways is poorly understood. We show that Polymerase Theta mediated end-
joining (TMEJ) accounts for most repair associated with microhomologies, and is made 
efficient by coupling a microhomology search to removal of nonhomologous tails and 
microhomology-primed synthesis across broken ends. In contrast to NHEJ, TMEJ 
efficiently repairs end structures expected after aborted homology-directed repair (5’ to 
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3’ resected ends) or replication fork collapse. It typically does not compete with 
canonical repair pathways, but in NHEJ-deficient cells is engaged more frequently and 
protects against translocation. Cell viability is also severely impaired upon combined 
deficiency in Pol q and a factor that antagonizes end resection (Ku or 53BP1). TMEJ 
thus employs a flexible mechanism to help sustain cell viability and genome stability by 
rescuing chromosome break repair when resection is misregulated or NHEJ is 
compromised. 
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CHAPTER 1: INTRODUCTION 
 
 
 
1.1 DNA double strand break repair 
 
DNA double strand breaks (DSBs) are a rare but potentially lethal class of genomic 
damage. DSBs are generated by both exogenous agents (e.g. ionizing radiation (IR) 
and chemical mutagens) and during endogenous processes (e.g. meiotic recombination 
and V(D)J recombination). Efficient DSB repair is essential for maintaining genome 
integrity and cell viability, as unrepaired DSBs can induce apoptosis. On the organismal 
level, deficiencies in DSB repair display as phenotypes including accelerated aging, 
immunodeficiency, and cancer predisposition1-5. Induction of DSBs is the basis of many 
frontline cancer treatments, including IR therapy and chemotherapeutic drugs such as 
etoposide and bleomycin. These therapies rely on overwhelming the capacity of DSB 
repair processes or exploiting repair deficiencies in the tumor cell, ultimately resulting in 
cell death. 
 There are two major pathways for resolving DSBs: nonhomologous end joining 
(NHEJ) and homologous recombination (HR)6 (Figure 1.1). In mammals, repair of DSBs 
proceeds predominantly by NHEJ7. NHEJ is a ligation pathway in which DSBs are 
resolved with little to no reliance on sequence homology at the breakpoint. This property 
of template independence allows NHEJ to be flexible with respect to damage at
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DSB termini and to be robustly active throughout the cell cycle, at the expense of repair 
fidelity8. Frequently, repair by NHEJ results in small insertion/deletion events at the 
repair junction. Inaccurate repair of DSBs can induce mutations and chromosomal 
rearrangements that harbor the propensity to become oncogenic. In contrast to NHEJ, 
the other major repair pathway, HR, performs high fidelity repair of DSBs by using a 
sister chromatid or homologous chromosome as a template to direct repair. As such, 
HR is active only during S and G2 phases of the cell cycle when an undamaged 
template is available9,10. 
While NHEJ and HR are the predominant DSB repair pathways, a third, loosely 
described repair option termed both alternative end joining (Alt-EJ) and microhomology-
mediated end joining (MMEJ) has been observed, primarily in systems that are deficient 
in classical NHEJ11-15 (Figure 1.1). Alt-EJ/MMEJ is thought to be a “back-up” repair 
pathway, that while minor, may have significant effects on genome integrity that are not 
yet understood.  
 
1.2 Nonhomologous end joining 
 
  The NHEJ core complex consists of the Ku heterodimer (Ku70:Ku80), DNA-
PKCS, XLF, and the DNA Ligase IV:XRCC4 complex16. NHEJ is initiated by the loading 
of Ku onto exposed DSB termini. The Ku heterodimer forms a ring structure that binds 
DNA with high affinity through a central channel and has the ability to translocate on 
DNA and peel DNA from chromatin17-22. In addition to direct roles in end processing, 
including 5’dRP lyase activity for the removal of nucleotide damage at the break termini, 
Ku serves as important hub for the recruitment of other NHEJ factors23-25. In the next 
step, DNA-PKCS interacts with Ku at the site of the DSB to form the DNA-PK 
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holoenzyme. This large kinase forms a synaptic complex that bridges and aligns the 
broken ends26. Additionally, DNA-PK regulates access of processing factors such as 
polymerases and nucleases to the break ends, with autophosphorylation of DNA-PKcs 
mediating the remodeling of the synaptic complex to allow access27,28. Finally, the ligase 
complex consisting of DNA Ligase IV, with XRCC4 and XLF forming a stabilizing 
filament, ligates the aligned double strand break ends, thus restoring genome integrity29-
34. DNA Ligase IV is a flexible translesion ligase that can tolerate mismatch distortions 
and some damage such as 8-oxo guanine nucleotides at the repair junction35. 
 The termini of DSBs are rarely fully complementary, and frequently have 
associated nucleotide damage. Common damages include base mismatches, oxidized 
nucleotides, abasic sites (where the nitrogenous base is lost and only the sugar-
phosphate backbone remains), and bulky adducts such as alkyl groups or covalently 
linked proteins36-38. A host of accessory processing factors associate with the NHEJ 
core complex to aide in the resolution of these damages. These factors include 
nucleases (e.g. Artemis), specialized factors for removing protein adducts (e.g. Tdp2), 
and X-family DNA polymerases (e.g. Pol l and Pol µ)39-42. Of particular interest, these 
polymerases associate with the NHEJ core complex via BRCT domains and allow for 
alignment and gap filling synthesis of breaks that would otherwise require more 
extensive deletion to repair43. Pol l and Pol µ are each individually active on cognate 
substrates and single loss of either enzyme is well tolerated by cells; yet double 
deficiency in both polymerases results in a sensitivity to ionizing radiation on-par with 
the loss of Ku44. Despite the incredible end-processing and ligation flexibility endowed to 
NHEJ, there arise times when damage is too severe, or cell cycle conditions dictate that 
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extensive nucleolytic processing of the DSB and resolution by a different pathway is 
preferred. 
 
1.3 DNA end resection 
 
DNA end resection is the 5’ to 3’ degradation of DSB termini, resulting in the 
generation of long 3’ single-stranded DNA (ssDNA) tails. Resection is a tightly regulated 
process with a host of both pro- and anti-resection factors that control the fate of the 
DSB. Pro-resection factors include the MRN complex (MRE11, Rad50, and Nbs1), CtIP, 
and BRCA145-47. A general model for resection involves the recognition of a break by 
the MRN complex, followed by nicking of the DNA by the endonuclease activity of 
MRE11 and 3’-5’ degradation towards the break termini by the exonuclease activity of 
MRE1148-52. CtIP is recruited to the MRN complex by the Nbs1 component and is an 
essential accessory factor for Mre11 nuclease activity in this process53-55. BRCA1, 
though not essential for resection, is thought to increase the initial rate of resection 
through CtIP56,57. This initial processing results in relatively short 3’ overhangs, on the 
order of 25-50 base pairs (bp). Subsequently, exonucleases and RecQ helicases such 
as ExoI, DNA2, and BLM are recruited to processively unwind and resect much larger 
tracts of DNA58. 
Proper regulation of resection is crucial for optimal repair pathway choice. Anti-
resection factors include 53BP1, RIF1, PTIP, and Ku59-64. 53BP1 is recruited to DSBs 
through the reading of both methyl and ubiquitin marks on histones at sites of damage 
and serves as a scaffold for the recruitment of downstream anti-resection factors65,66. 
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These factors suppress resection by physically blocking the accessibility of the DNA 
ends to pro-resection nucleases, thus promoting repair by NHEJ.  
 
1.3.1 Initiation of homologous recombination 
Repair by HR is essential for organismal development and is a major mediator of 
genetic diversity through meiotic recombination. The ssDNA tails exposed by end 
resection are an essential structural intermediate in the initiation of DSB repair by HR67. 
As the resection machinery exposes DNA tails, they are quickly coated by the trimeric 
ssDNA binding protein RPA and are protected from degradation by cellular nucleases 
and the formation of secondary DNA structures68. Subsequently, RPA is displaced from 
the ssDNA tails by the Rad51 recombinase. This exchange is promoted through BRCA2 
and DSS1, which bind Rad51 monomers and destabilize RPAs affinity for ssDNA 
respectively, allowing Rad51 to properly bind and nucleate a protein:DNA filament along 
resected 3’ ends69-74. The Rad51-coated nucleofilament then proceeds to invade the 
sister chromatid and search for homology between the resected end and the template 
chromosome75. Subsequently, a host of late-stage HR factors use the ssDNA tail as a 
primer to direct high-fidelity DNA synthesis off the intact template chromosome, and 
resolve the break via mechanisms that can result in either a crossover or non-crossover 
of genetic information between chromosomes. 
 
 
1.4 Alternative end joining 
 
The third DSB repair pathway, Alt-EJ/MMEJ, is poorly characterized relative to 
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both NHEJ and HR. This pathway has been defined primarily in the background of 
NHEJ deficiency and initially manifested as the observation that DSB repair junctions in 
the absence of NHEJ tended to join using small patches of complementary DNA 
("microhomology”) derived from sequence flanking the DSB76,77. Genetic analysis of this 
class of repair has provided evidence that Alt-EJ is dependent on the MRN complex and 
CtIP (and their orthologs MRX and Sae2, respectively, in S. cerevisiae), suggesting that 
like HR, Alt-EJ acts downstream of resection78-80. 
 Very little is known about the cellular roles, context, and factors that are involved 
in the repair by of Alt-EJ. Alt-EJ appears to have some contribution to class switch 
recombination, where microhomology usage can occur during heavy chain 
rearrangement to generate different antibody isotypes, though a defined role in normal 
cellular repair remains elusive81,82. It has been suggested that Alt-EJ is dependent on 
the activity of Poly(ADP)ribose polymerase 1 (PARP1), as well as DNA Ligase I and 
DNA Ligase III83-86. Specifically, depletion of Ligase III leads to a decrease in 
microhomology-mediated chromosomal translocation junctions. These studies have 
tended to rely on the indirect output of reporter assays and bear further investigation, as 
there appear to be discrepancies between reporters both within and across species. 
Recently, studies have proposed a role for DNA Polymerase q (Pol q, Polq) in Alt-
EJ/MMEJ. 
 
1.5 DNA Polymerase q 
 
Pol q is a 290 kDa protein encoded by the gene POLQ. Orthologs of this enzyme 
are found in most eukaryotes, but are not present in S. cerevisiae. Pol q has a unique, 
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evolutionarily conserved domain structure consisting of a superfamily II helicase-like 
domain in the N-terminal third of the protein, a disordered central domain of unknown 
function, and an A-family polymerase domain in the C-terminal third87. The helicase-like 
domain does not appear to have any DNA unwinding activity, but does harbor an active 
ATPase motif88. Additionally, this domain harbors several putative Rad51 interaction 
motifs89. Recent structural studies of the helicase-like domain have proposed that the 
domain may serve as a ssDNA binding module, in which 3’ overhang structures are 
channeled through a central region in the domain90. At the C-terminal end of the protein, 
the polymerase domain shares sequence identity with the other mammalian A-family 
polymerases, Pol n and Pol g, yet structurally diverges by the acquisition of 3 loop 
inserts91. Crystallization of this domain bound to DNA shows that these loop inserts 
make novel stabilizing contacts with DNA near the polymerase active site92.  
 
1.5.1 In vitro characterization of Polymerase q 
Pol q has activity in vitro that is consistent with a relatively low fidelity DNA 
polymerase. The enzyme displays moderate processivity (up to 75 bp in a single round 
of extension), a single-base error rate (2.4x10-3) similar to Y-family translesion 
polymerases such as Pol k, and does in fact display some translesion synthesis 
activity93. For example, Pol q can bypass thymine-glycol adducts and incorporate 
nucleotides across from abasic sites94,95. Further, Pol q has the ability to extend 
following this base incorporation event, which could be biologically useful in the repair of 
damaged DNA. The polymerase also has a unique activity in that it can extend 3’ 
ssDNA in both template-dependent and -independent manners, but only if the overhang 
	 8	
is far from duplexed DNA (at least 14 bp from duplex)96. This is opposite of X-family 
polymerases, which can perform template independent synthesis only when overhangs 
are short (< 4 nt).  Finally, though the protein contains the evolutionary remnants of a 3’-
5’ exonuclease “proofreading” domain, it maintains no nucleolytic activity in vitro92. 
 
1.5.2 Polymerase q and DSB repair 
Several in vivo studies are strongly suggestive of a role for Pol q in protecting 
genome stability, though there do appear to be subtle variations in Pol q activities 
depending on species. The earliest studies of Pol q as a mediator of genome stability 
came from a screen in which the chaos1 allele, a mutation in mouse chromosome 16 
that correlated with increased levels of micronuclei in blood samples (an indicator of 
chromosomal fragmentation), was determined to be a point mutation in Pol q97. Further 
investigation of this phenotype by the generation of a full knockout mouse confirmed 
that loss of Pol q was the causative agent of this instability. Of interest, mice made 
doubly deficient in Pol q and ATM, a master regulator kinase of repair by HR, die during 
embryonic development, suggesting that  Pol q is involved in maintaining genome 
stability in a manner distinct from classical HR repair98. 
Pioneering studies in three model organisms (D. melanogaster, C. elegans, and M. 
musculus) have reached the accord that Pol q mediates a non-canonical DSB repair 
pathway, though with some evolutionary differences in cellular roles. The first direct 
reports of Pol q involvement in a DSB repair pathway came from D. melanogaster, 
where end joining junctions following p-element excision only contained 
microhomologies in the presence of the Pol q ortholog Mus30899. Further, these repair 
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junctions frequently contained templated insertion events that could be attributed to one 
or more microhomology dependent intra-molecular priming events100. Drosophila 
studies have also identified a role for Mus308 in the repair of inter-strand crosslinks 
(ICLs); a class of repair that typically involves a DSB intermediate101.  
Similarly, work in C. elegans has shown a crucial role for Pol q in repair of complex 
replication blocks such as G-quadraplex DNA structures, CRISPR/Cas9 breaks, and 
damage induced by crosslinking agents102-105. Further, Pol q appears to be a mediator 
of C. elegans germline mutagenesis and evolution through a mechanism that utilizes 
exactly one nucleotide of microhomology at DSB repair junctions106.  
Studies in mammalian systems have further confirmed a role for Pol q in DSB repair, 
while highlighting evolutionary differences. Treatment of both WT and Pol q-deficient 
murine bone marrow stromal cells with a variety of damaging agents showed that Pol q 
confers a specific resistance to classical DSB inducing agents such as ionizing radiation 
and etoposide, but not to ICL inducing agents (Figure 1.2)107. These studies in 
mammalian systems have also addressed the broad role of Pol q in genome stability 
through translocation formation. Translocations result from the aberrant joining of two 
DSBs on different chromosomes and are a common rearrangement in many cancers. 
Work in murine and human cells has suggested opposing roles for Pol q in translocation 
formation (a suppressive role in mice compared with a promoting role in human), though 
the methods in each study varied substantially (spontaneous IgH:Myc translocation in 
mice compared with CRISPR/Cas9 induced breaks in human)107,108. 
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1.6  Polymerase q and cancer 
 
Several types of cancer including stomach, lung, colorectal, and breast cancer have 
been associated with elevated Pol q expression. Further, cancers overexpressing Pol q 
are significantly associated with poor patient survival109. The relationship between Pol q 
and breast cancer is currently the most explored association and in fact, expression 
levels of Pol q and a cohort of its neighboring genes appear to be diagnostic for triple 
negative breast cancer110. Two single nucleotide polymorphisms (SNPs) in or near the 
POLQ gene have also been identified and associated with hereditary breast cancer in a 
case-control study of patients with either hereditary or sporadic breast cancers111. A 
SNP in the promoter region of the gene was most strongly associated, though the 
mechanistic implications of this SNP are unknown. 
Recently, studies have suggested that Pol q may be be a promising target in battling 
chemotherapeutic resistance. Co-inhibition of Pol q and some HR-involved genes re-
sensitized cisplatin-resistant lung cancer cells to the drug112. Similarly, inhibition of Pol q 
greatly sensitized HR deficient tumor cell lines to a variety of cytotoxic agents including 
PARP inhibitors (PARPi). Most strikingly, relative tumor volume, clonogenic survival, 
and organismal survival were all positively impacted by depletion of Pol q combined with 
PARPi therapy in a murine FANCD2-null xenograft model89. These results rationalize 
the exploration of Pol q as a therapeutic candidate for the treatment of some cancers 
and highlight the need for a deeper mechanistic understanding of the enzyme and its 
contribution to cellular DSB repair. 
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Figure 1.1: DNA double strand break repair pathways. 
Cells repair DSBs through the nonhomologous end joining, homologous recombination, 
and alternative end joining/microhomology-mediated end joining pathways. 
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Figure 1.2: Hypersensitivity of Polq-/- bone marrow stromal cells to DNA strand-
breaking agents. 
 
 
BMSCs were exposed to x-rays or UVC at the indicated doses, and to etoposide, ICRF-
193, camptothecin, olaparib, temozolomide, mitomycin c, cisplatin, and HMT 
psoralen+UVA at the indicated concentrations and plated in triplicate. Two isogenic 
bone marrow stromal cell lines were used of each genotype, Polq+/+ or Polq-/-. Colonies 
were stained and counted seven to ten days later. 
 
 
 
 
 
 
 
 
 
 
The DNA polymerase activity of POLQ is required to
confer resistance to DNA damaging agents
We sought next to investigate which catalytic activities of POLQ
are necessary to confer resistance to DNA damaging agents.
Lentiviral-delivered expression vectors were constructed to express
wild-type or mutant versions of POLQ in immortalized MEFs, in
order to test for functional complementation (Figure 3A). A
tandem (D2330A,Y2331A) mutation was introduced into the
DNA polymerase domain (POL); mutation of the corresponding
residues in other DNA polymerases completely inactivates
polymerase activity [27]. In a separate construct, a mutation was
introduced into the conserved ATP-binding site of the Walker A
motif (K121M) in the helicase-like domain (HLD). An equivalent
mutation eliminates DNA helicase activity in related enzymes,
including HELQ [28]. A third construct (DM) was made
harboring mutations in both domains. These vectors expressed
full-length recombinant POLQ as tested in transfected 293T cells
(Figure 3B and C).
The mutant cDNAs were tested for their ability to genetically
complement the bleomycin sensitivity ofPolq-null MEFs. Stable
clones with each of the constructs were generated and analyzed for
expression of POLQ (Figure 3D). Independent clones of knockout
MEFs expressing wild-type recombinant POLQ (WT4 and WT6)
were able to rescue bleomycin hypersensitivity (Figure 3E) as an
antibody that recognizes endogenous POLQ does not yet exist.
Neither the polymerase domain mutant (POL) nor the polymer-
ase-helicase double mutant (DM) restored bleomycin sensitivity
(Figure 3E, Figure S1B). Expression of a construct with a mutation
only in the helicase-like domain (HLD) was, however, still able to
restore resistance to bleomycin. These data indicate that POLQ
polymerase activity is essential for conferring resistance to DNA
damage, while the ATPase activity of the helicase-like domain is
not necessary. Similarly reintroduction of polymerase activity of
POLQ into Polq-deficient MEFs was able to rescue chromosomal
instability (micronuclei and DNA DSBs, as measured by 53BP1
and cH2AX colocalization (Figure 3F and 3G, Figure S2).
Mice with an S1932P mutation in Polq (the ‘‘chaos1’’ allele)
have an increased spontaneous frequency of micronuclei [13]. We
generated a humanPOLQ cDNA mimicking the chaos1mutation
(S1977P), but attempted expression of POLQ with this mutation
in 293T cells did not yield detectable protein (Figure S3). This
suggests that thechaos1-encoded mutant protein is unstable,
consistent with the finding thatchaos1mice have a phenotype
essentially indistinguishable fromPolq knockout mice [13].
POLQ operates in a pathway of altEJ during mouse Ig
class-switching
Immunoglobulin class-switch recombination (CSR) uses DNA
end joining to exchange one constant region of an antibody gene
for another constant region. CSR can occur by both Ku-
dependent classical non-homologous end joining and Ku-inde-
pendent altEJ [20]. The overall frequencies of CSR are similar in
Polq-defective mice [29] and cultured B cells [30]. To determine
whether POLQ is involved in a mechanistically distinct subset of
Figure 1. Hypersensitivity of Polq2 /2 bone marrow stromal cells to DNA strand-breaking agents. BMSCs were exposed to x-rays or UVC
at the indicated doses, and to etoposide, ICRF-193, camptothecin, olaparib, temozolomide, mitomycin c, cisplatin, and HMT psoralen+UVA at the
indicated concentrations and plated in triplicate. Two isogenic bone marrow stromal cell lines were used of each genotype, Polq+/+ or Polq2 /2 .
Colonies were crystal violet stained and counted seven to ten days later. Experiments were repeated three times. Circles, Polq+/+ clone 1; Squares,
Polq+/+ clone 1; Triangles, Polq2 /2 clone 1; invert d triangles, Polq2 /2 clone 3.
doi:10.1371/journal.pgen.1004654.g001
Insertional POLQ-Dependent DNA Strand Break Repair
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CHAPTER 2: MECHANISM OF POLYMERASE q-MEDIATED END JOINING 
 
2.1 Introduction 
DNA double-strand breaks (DSBs) can arise via a number of different exogenous 
exposures (e.g. ionizing radiation or chemotherapeutics), as well as through 
endogenous processes such as V(D)J recombination during immune system 
diversification and during normal cellular duplication cycles, when DNA replication stalls 
at naturally occurring structures or at sites of internally-generated DNA damage. 
Because DSBs are toxic and/or mutagenic if not repaired, organisms have multiple 
mechanisms for DSB repair113,114. The primary strategies are nonhomologous end 
joining (NHEJ), which processes and rejoins DSBs independent of sequence homology, 
and homologous recombination (HR) which employs an undamaged copy of the DNA 
for high fidelity repair115. In addition to these canonically studied repair processes, one 
or more “alternative” end joining pathways (Alt-EJ) also exist, which are independent of 
these factors116,117.  
Alt-EJ in eukaryotic cells has been linked to activity of DNA polymerase theta 
(Pol q; encoded by Polq)107. This large, 290 kDa protein has an unusual bipartite 
structure with an N-terminal helicase-like domain and a C-terminal DNA polymerase 
domain88. This domain arrangement and the Pol q protein sequence is highly conserved 
in vertebrates87. 
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Several functions have been suggested for Pol q, including bypass of template 
DNA lesions such as abasic sites and thymine glycols95,118, a backup role in DNA base 
excision repair119,120, and influencing the timing of DNA replication origin firing121. Loss 
of Pol q homologs in Drosophila and C. elegans causes hypersensitivity to DNA 
interstrand crosslink (ICL)-forming agents122,123 such as nitrogen mustards or cisplatin, 
while mammalian cells lacking Pol q are uniquely sensitive to DSB inducing agents, 
such as ionizing radiation.  
The mechanistic constraints on Pol q activity in cellular repair are still unclear. We 
investigated these questions through use of extrachromosomal assays and a panel of 
mouse embryo fibroblast lines (MEF) cell lines deficient in Polq and Ku70. Our results 
provide insight into how Pol q activity contributes to cellular DSB repair. We show Pol q 
activity is facilitated by an ability to couple microhomology primed synthesis to a 
“microhomology search” and removal of non-homologous tails. We further identify an 
essential role for this enzyme in repair of DSBs in contexts where ends are inaccessible 
to canonical NHEJ, as is the case when resected ends exceed 45 nt in length, or at “Y” 
structures expected during replication fork collapse. 
 
2.2 Methods 
Cell lines 
Experiments varying Polq status employed SV-40 Large T antigen transformed 
MEFs recovered from mice where a Polq null allele was generated by conventional 
gene targeting and made isogenic by backcrossing in mice. Polq-/- MEFs were then 
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complemented by lentiviral delivery of cDNA coding wild type human Polq. Deficiency or 
complementation was assessed by RT-qPCR for mRNA expression relative to a 
housekeeping control (GAPDH) (Figure 2.1A). 
Variants of the above WT and Polq-/- lines deficient in the Ku70 gene were made 
following transient expression of Cas9 and sgRNA targeting exon 3 of Ku70. Following 
Cas9 mutagenesis, cells were subcloned and screened for biallelic frameshift 
mutations. Complemented variants of these Ku70 deficient lines were made with 
lentivirus delivering mouse Ku70 cDNA. Ku70 deficiency or complementation was 
validated by western analysis (Figure 2.1B) and a functional assay for NHEJ activity 
(Figure 2.1C). All cell lines were cultured in DMEM with 10% FBS (Sigma), 2 mM L-
Glutamine (Gibco), 1x penicillin-streptomycin, and 2 ug/ml puromycin, 4 ug/ml 
blasticidin, or 0.5 mg/ml G418 as necessary for transgene maintenance.  
Substrate preparation 
 Substrates were prepared using a variation of the golden gate cloning method. A 
596 base pair common core DNA segment was amplified by PCR and digested with 
BsaI-HF (NEB) to yield 4 nucleotide overhangs where head and tail overhang had 
distinct sequence. Caps with a common 15 bp double stranded region and overhangs 
specific for core head and tail ends were assembled by annealing of oligonucleotides 
(IDT), then ligating the caps to the core fragment, generate the linear fragments with 
head and tail end structures varied as noted in Table 2.1. Excess cap was removed 
using the QIAquick PCR purification kit (Qiagen) and substrate purity validated by 
polyacrylamide gel electrophoresis on a 4% gel. 
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Extrachromosomal end joining assay 
 DNA substrates (75 ng) of the noted substrate and pMAX-GFP (1 ug, Lonza) 
were introduced into 2x105 cells by electroporation (Neon, Invitrogen) using a 1350 V, 
30 ms pulse in a 10 μL chamber and incubated for 1 hour. Cells were washed, 
incubated with 12.5U of Benzonase (Sigma) to digest extracellular substrate, and 
cellular DNA purified (QIAamp DNA mini kit, Qiagen) to determine substrate joining 
efficiency and junction character by sequencing. Joining efficiency of extrachromosomal 
substrates introduced into cells was quantified by qPCR using either primers Sub 
Duplex Fwd/Rev or primers Sub Overhang Fwd/Rev, depending on the experiment. 
Total substrate recovery (both joined and unjoined) was determined as a validation of 
transfection efficiency across genotypes by qPCR using primers Sub Recovery 
Fwd/Rev. All PCRs were confirmed to be >98% efficient over the range relevant to 
these experiments by parallel analysis of a standard curve generated by serial dilution 
of model amplicons. Product structures were characterized by polyacrylamide gel 
electrophoresis on an 8% gel with SYBR green staining or sequencing.  
Sequencing 
 Template DNA for each sequencing library was from independent 
electroporations performed across three days. 1x105 input junction molecules were 
amplified using Phusion DNA polymerase (NEB) and variants of the qPCR primers 
noted above, with the addition of 6 nt barcode sequences appended to their 5’ ends for 
21 cycles. 15.5 ng of amplified DNA from each library was pooled in groups of ~10 
libraries, phosphorylated with T4 PNK (NEB), treated with dATP and Klenow Exo – 
(NEB) to adenylate the 3’ termini. Adaptors for sequencing (Illumina) were then 
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appended to the amplicons by ligation, and free adaptor removed by gel purification. 
Gel purified pooled libraries were subjected to a 10 cycle enrichment amplification with 
adaptor-specific primers and purified with Ampure XP beads (Agencourt, Beckman 
Coulter). Equal amounts of DNA from each pooled library set were combined and 
submitted for a 2x150 paired end sequencing run (MiSeq, Illumina), with a PhiX174 
DNA spike. 
 After sequencing, reads of PhiX174 DNA were removed. Remaining reads were 
then trimmed for quality, paired ends were merged, and libraries were de-indexed using 
Genomics workbench v8.0 (CLC-Bio). Characterization of substrate repair junctions was 
performed by alignment of reads to a reference junction, export in SAM format, and 
deconstruction of the CIGAR string in Excel (Microsoft) to yield parameters including 
flanking deletion, length of ssDNA tails generated, and microhomology content at the 
junction.  
Gel shift assay 
Cy-5 labeled DNA substrates were generated by annealing of oligonucleotides to 
generate a 20 bp duplex core. Subsequent ligation of cap structures generated 
substrates with either 4 nt or 70 nt 3’ ssDNA overhangs. Resulting substrates (5 nM) 
were incubated with 500 nM Streptavidin for 10 minutes at room temperature, then 
incubated with 5nM Ku for 5 minutes at 37°C in 1x EMSA buffer (20 mM Tris pH 8.0, 90 
mM NaCl, 25 mM KCl, and 10% glycerol) at 37°C before addition of a 10-fold excess of 
unlabeled dsDNA and electrophoresis.  
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Strand displacement assay 
 Substrates bearing either 4 nt or 45 nt 3’ overhangs were prepared as described 
above, with the variation that substrates now contained a mispaired BamHI restriction 
endonuclease site embedded 15 bp into the duplex DNA adjacent to the 3’ overhangs. 
Substrate variations also contained either a 5’ phosphate or 5’ THF. The restriction site 
was mispaired such that 4 out of 6 positions of the BamHI recognition site were 
mispaired. Substrates were introduced into WT MEFs by electroporation as described 
above and harvested after 1 hr. Repair junctions were digesting with BamHI overnight at 
37°C in a 20 ul reaction volume then used as template in a PCR amplification using 
primers Sub Duplex Fwd/Rev. Products were analyzed by PAGE electrophoresis on a 
6% gel and qPCR.   
 
2.3 Results 
Distinct substrates for NHEJ and Pol q-mediated end joining 
We previously showed that Pol q is required for a cellular end joining pathway – 
Polymerase q mediated end joining, or TMEJ – that is independent of Ku, and uniquely 
able to join ends with extended 3’ssDNA tails107. To better address the relationship 
between TMEJ and classically defined NHEJ we sought to make cell lines deficient in 
one or the other pathway, or both. We consequently employed CRISPR/Cas9 to 
generate variants of existing isogenic wild type and Polq-/- MEF lines107(Figure 2.1A) 
that do not express significant Ku70 protein (Figure 2.1B). These lines are deficient in 
NHEJ, and can be complemented by expression of introduced Ku70 cDNA (Figure 
2.1C). 
	 19	
The progressive 5’ to 3’ resection of DSB termini is a necessary pre-requisite for 
repair of DSBs by homologous recombination (HR). To address how resection affects 
the deployment of different end joining pathways we introduced a panel of linear double 
stranded DNA substrates with “pre-resected” ends, where 3’ ssDNA overhangs ranged 
from 4-70 nucleotides (nt) (Figure 2.2A, Figure 2.6A), into the cell lines described 
above. Head and tail overhang sequence were designed such that the terminal 4 nt 
were complementary, i.e. contain a microhomology. The impact of differing location and 
length of microhomologies is discussed in greater detail below.  
Overall joining efficiency was reduced 5-10 fold for overhang lengths in excess of 10 
nucleotides, and two populations of end joining products were readily evident; one 
where most of both overhangs had been removed, and another where most of both 
overhangs had been retained (Figure 2.2B-D). As overhang length is increased, joining 
is progressively more reliant on products where most of both overhangs are retained 
(Figure 2.6A, 2.6B). In all contexts joining after overhang loss was largely dependent on 
Ku70/NHEJ, while joining associated with retention of 3’ overhangs was dependent on 
Pol q (bottom panels, Figure 2.2B-D). Pol q additionally was not required for either 
product class (overhangs retained and overhangs lost) using a substrate where the 
overhang polarity was reversed (5’ overhang), but which was otherwise equivalent 
(Figure 2.6C). TMEJ is thus uniquely employed for repair of products of 5’>3’ resection.  
When the 3’ overhang was only 45 nt, overall joining efficiency was reduced 3-fold in 
Ku70 deficient cells and not affected by Pol q deficiency (Figure 2.2B, top panel). In 
contrast, the reciprocal pattern was observed when overhang length was increased to 
70 nt (Figure 2.2C, top panel). Only trace levels of end joining were observed for both 
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substrate variants in cells deficient in both Pol q and Ku70 (Figure 2.2B, 2.2C, top 
panels). The two pathways thus together account for most of the cellular capacity to 
repair pre-resected end structures, but TMEJ assumes prominence as the extent of 
5’>3’ resection exceeds 45 nt (see also Figure 2.6B). 
We reasoned that this increased reliance on Pol q-dependent repair as the ssDNA 
tails are extended reflects a reduced ability of the Ku heterodimer to load on substrates 
with long ssDNA tails (Figure 2.6C). To further investigate this possibility, we generated 
a variant of the shorter 45 nt 3’ overhang with a “Y” or forked end structure, by including 
a 5’ streptavidin-blocked flap (Figure 2.2D). Such a substrate is expected to completely 
block loading of Ku, and is analogous to products of replication fork collapse (“one 
ended breaks”). Accordingly, we observed no significant impact of Ku-dependent NHEJ 
when using this substrate. Repair was instead Pol q-dependent (Figure 2.2D, top 
panel), consisted almost entirely of products that retained the majority of both 3’ 
overhangs (Figure 2.2D, bottom panel), and thus can be readily defined as TMEJ. We 
conclude Pol q-dependent repair is most important when considering end structures 
where loading of Ku is impaired. This includes those end structures expected after 
aborted HR – ends with extended 3’ ssDNA tails - or after replication fork collapse. 
Mechanism of Pol q-mediated end joining 
Products that retain significant amounts of overhang are mostly dependent on Pol q; 
conversely, Pol q deficiency had little impact on either the efficiency or structure of those 
products generated after overhang loss (Figure 2.2). Relocation of qPCR primers to 
require that end joining products retain at least 10 nt of each overhang is thus sufficient 
to restrict analysis to Pol q-mediated events107(Figure 2.3A).  
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Pol q is a multi-domain protein, with an N-terminal helicase-like domain and a C-
terminal polymerase domain (Figure 2.7A). To investigate the contributions of each 
activity we compared the ability to complement Polq-/- cells for TMEJ capacity by 
expression of the wild type Polq cDNA, a variant cDNA with a mutation inactivating 
ATPase activity of the helicase domain (K121M), or a variant cDNA with mutations that 
inactivate the polymerase domain (D2330A/Y2331A; Motif A)107. Levels of TMEJ in cells 
expressing the D2330A/Y2331A construct were indistinguishable from cells with an 
empty vector control (Figure 2.3A); polymerase activity is thus essential for this 
pathway. In contrast, loss of ATPase activity in the helicase-like domain had no 
significant impact on joining efficiency, but did affect product spectra (discussed below). 
We also assessed a possible role for Pol µ and Pol l, which have previously been 
associated with an ability to direct intermolecular DNA synthesis, i.e. can prime 
synthesis from a 3’ tail from one DSB end, and use a second DSB end as template44. 
Both of these polymerases are dispensable for cellular end joining using pre-resected 
substrates (Figure 2.3A), with levels of TMEJ instead increased in cells deficient in both 
Pol µ and Pol l. This may reflect the important role of these polymerases in NHEJ, and 
increased TMEJ in NHEJ-deficient contexts.  
The substrates described above were designed such that the terminal 4 nt were 
complementary, to allow for alignment-directed synthesis. Surprisingly, products 
consistent with synthesis from these terminal alignments accounted for only 56% of 
TMEJ when using the 45 nt 3’ overhang substrate, and 20% of TMEJ when using the 70 
nt 3’ overhang substrate (Figure 2.3B; Table 2.2). Remaining products favored 
alignments with short complementary sequences found internally (“embedded” 
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alignments). For example, repair of the 70 nt overhang substrate frequently employed 
all four of the alignments that are greater than 3 bp and can also be found within 25 nt 
of the 3’ ends. Taken together, these 4 products account for 2/3rds of all products 
recovered (Figure 2.3B), with the three embedded alignments used almost twice as 
often as the terminal alignment. Moreover, there were only mild effects on the efficiency 
of repair when using a substrate where both the terminal and most favored embedded 
alignments were disrupted (Figure 2.7B). We additionally did not see significant 
recovery of products where an embedded alignment directed synthesis from a 
mispaired tail (Figure 2.3B). We can therefore infer synthesis by Pol q using embedded 
alignments is efficiently coupled to a prior step where the unpaired tail is removed.  
Notably, the ability to use embedded alignments was modestly reduced in cells 
expressing the Pol q variant with an ATPase inactivating mutation (K121M; Figure 
2.3C). This suggests TMEJ is facilitated by an active search for complementary 
sequence alignments (i.e. microhomology in finished product) that involves ATPase 
activity in the N-terminal helicase-like domain. Characterization of products also clarifies 
the constraints on this putative microhomology search mechanism. Considering first the 
amount of complementary sequence, only those products with alignments > 2bp were 
significantly enriched (Figure 2.3D). However, the length of nonhomologous tails 
impacts the ability to use such alignments. For example, a product generated from a 6 
bp alignment, but which would generate long nonhomologous tails (52 nt and 22 nt), is 
observed 20-fold less frequently than a 4 bp alignment with short tails (9 nt and 2 nt, 
Figure 2.3B). Alignments resulting in tails with one long and one short tail (e.g. 51 nt 
and 4nt, Figure 2.3B) are also rarely used, suggesting a need to recognize both 3’ 
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termini. In sum, 91% of products recovered using the 70 nucleotide overhang substrate 
(140 nt of ssDNA) have deletion less than 50 bp (Table 2.2).  
Moreover, we show here that the synthesis activity of TMEJ does not terminate 
at a downstream 5’ phosphate and instead involves a strand displacement intermediate. 
Repair of substrate containing a BamHI site on the template strand that is mispaired 
and buried 15 bp into the substrate duplex is not sensitive to restriction enzyme digest 
when overhang length is 4 nt and thus repaired by NHEJ (Figure 2.4A, 2.4B). Joining of 
this substrate is reduced when the 5’ phosphate is replaced with a 5’ abasic site mimetic 
(e.g. THF). In contrast, when the overhang length is extended to 45 nt, the substrate is 
repaired by TMEJ and junctions are rendered sensitive to pre-amplification digestion by 
BamHI (Figure 2.4B). Further, joining of this substrate not influenced by the presence of 
a 5’ abasic site in lieu of a 5’ phosphate. This result confirms that the synthesis step of 
TMEJ preferentially displaces the mispaired strand and uses the intact BamHI-
containing strand as template in a “long patch” DSB repair process.      
 
2.4 Discussion 
Our results indicate that in cells, Pol q has a central role in an end joining pathway – 
TMEJ – that is uniquely able to repair substrates where classically defined NHEJ is 
ineffective (Figure 2.2). The effects of Pol q deficiency on both which substrates can be 
joined (Figure 2.2) and product spectra (Figure 2.3, 2.4) indicates that in mammals, Pol 
q/TMEJ is required for most of what had previously been defined as MMEJ or Alt-NHEJ. 
Characterization of these products further argues TMEJ is an organized pathway, as 
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synthesis by Pol q is coupled to two prior steps, including a search for microhomology 
and removal of nonhomologous tails (Figure 2.3).  
Identification of biologically significant substrates and mechanism 
We show there are marked differences between cellular TMEJ and the in vitro 
activities of the truncated Pol q polymerase domain. TMEJ is uniquely required as 
ssDNA extensions exceed 45 nt (Figure 2.2), as well as forked ends (i.e. when a paired 
5’ terminus is unavailable); by comparison, in vitro studies124 indicate activity was limited 
to extensions 15 nt or shorter. We suggest full length Pol q may be intrinsically more 
processive93, Pol q may employ a processivity clamp (PCNA) during cellular TMEJ, or 
there may be polymerase switching after synthesis initiation. The unique activity on 
forked structures is consistent with studies identifying an important role for Pol q in 
replication fork re-start after fork collapse (“one-ended” chromosome breaks)89,103. 
Indeed, this result predicts TMEJ will be critical in joining any pair of ends where either 
of the 5’ termini is inaccessible to Ku or “unligatable”, i.e. has irreversible bulky adducts 
or is associated with extensive base damage. In accord with this prediction, we show 
that TMEJ is not impeded by a 5’ abasic site – a lesion that ablates joining by NHEJ 
(Figure 2.4). 
Cellular TMEJ is also rarely associated with synthesis from terminal mispairs (Figure 
2.3), as can be observed in in vitro studies of truncated Pol q activity124. This limitation 
could dramatically restrict the fraction of ends that could be joined (<1/64), given the 
requirement for annealing at significant microhomologies (3-6 bp) for synthesis. Our 
results indicate cellular TMEJ instead efficiently samples all of the useable alignments 
within the 3’ terminal 25 nt of a pair of ends, which is sufficient to enable efficient joining 
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of over 99% of ends of random sequence. The spectrum of cellular TMEJ products also 
emphasizes another advantage of a homology-search mechanism, its ability to mitigate 
deletion. 91% of TMEJ-dependent products of an extrachromosomal substrate with 140 
nucleotides of ssDNA have less than 50 bp (2x25) of deletion.  
Cellular TMEJ is thus made flexible, and deletion constrained, through an ability to 
tightly couple together three steps (Figure 2.5): 1) a microhomology search that usually 
generates nonhomologous tails, 2) excision of these tails, and 3) strand-displacement 
synthesis from the newly annealed 3’ terminus. The search for microhomology might be 
dependent on the Pol q N-terminal helicase-like domain, as suggested by a structural 
model for an oligomer of this domain that juxtaposes a pair of 3’ ssDNA termini90. In 
accord with this model, the ability to use embedded alignments is specifically impaired 
in cells expressing a Pol q mutation that inactivates this domain’s ATPase activity. 
Effects of ATPase activity on microhomology search could plausibly be explained if it 
drove adjustment of the relative position of the two aligned termini. With regard to the 
next step, removal of nonhomologous 3’ tails, Pol q has no intrinsic nuclease activity87. 
However, such an activity is present as a contaminant of Pol q partially purified from 
HeLa cells125, and results described here suggest this activity is tightly coupled to Pol q 
activity. Mre11 and XPF:ERCC1 are both attractive candidates for this nuclease activity, 
as they have appropriate substrate specificities and have already been implicated in Alt-
NHEJ/MMEJ77. The third step, synthesis from 3’ termini with 3-6 bp annealed, is 
facilitated by the tight grasp Pol q maintains on the primer termini92. Altogether, Pol q is 
uniquely suited to direct this pathway.  
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Figure 2.1: Validation of NHEJ deficient cells and complementation 
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Figure 2.1: Validation of NHEJ deficient cells and complementation 
 
(A) Levels of endogenous Polq or hPolq mRNA were assessed by a qPCR of reverse 
transcribed RNA recovered from the noted cell lines using primers that have equal 
sequence identity to both human and mouse Polq cDNA. Data are the mean +/- SEM, 
n=3, relative to the amount observed in WT (Polq+/+) MEFs. (B) Western blot of noted 
cell types assessing expression of endogenous Ku70 or introduced FLAG-tagged Ku70 
proteins. (C) A c-NHEJ substrate with head and tail 4 nt 3’ overhangs was introduced 
into noted cell types, and joining efficiency was assessed as described in Figure 2. Data 
are the mean +/- SEM, n=3. Statistical significance assessed by one-way ANOVA with 
Bonferoni correction.  
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Figure 2.2: Effect of end joining deficiencies on repair of pre-resected ends 
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Figure 2.2: Effect of end joining deficiencies on repair of pre-resected ends 
 
(A) Linear substrates with varied end structures were introduced into noted cell types 
and end joining products characterized by quantitative polymerase chain reaction (top 
panels) or electrophoresis of amplified products (bottom panels); Data shown below are 
the mean +/- SEM, n=3. Statistical significance was assessed by one-way ANOVA with 
Bonferoni correction of p values to account for multiple comparisons. NS not significant, 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. (B) A substrate with symmetrical 45 nt 3’ 
single stranded DNA overhangs was introduced into the noted cell types, and the mean 
efficiency of end joining determined by qPCR and expressed as a fraction of that 
observed in WT cells. Amplified products generated in a parallel fixed-cycle number 
PCR were also characterized by electrophoresis; products of size consistent with joining 
after overhang clipping vs. overhang retention are noted. (C) A substrate with 70 nt 3’ 
overhangs was introduced into the noted cell lines and joining characterized as 
described above. (D) A substrate as in panel B, except with a 20 nt non homologous tail 
ending in a 5’ terminal biotin-streptavidin group, was introduced into the noted cell lines 
and joining characterized as described above.  
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Figure 2.3:  Mechanism of Pol q mediated end joining 
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Figure 2.3:Mechanism of Pol q mediated end joining 
 
(A) The 45 nt 3’ overhang substrate described in Fig. 2B was introduced into cells that 
were WT, Polq-/-, and Polq-/- engineered to express wild type human Polq or variants 
deficient in helicase-like domain ATPase activity (K121M), or polymerase activity 
(D2330A+Y2331A), and joining efficiency assessed by qPCR using primers that require 
retention of at least 10 nt of each 3’ overhang sequence in junctions. Joining efficiency 
was also characterized in Poll-/- Polm-/- MEFs, relative to matched WT control MEFs. 
Data shown are the mean +/- SEM, n=3. Statistical significance was assessed by one-
way ANOVA with Bonferoni correction. NS =not significant, *p<0.05, **p<0.01, 
***p<0.001. (B) Observed frequency of different joining products of the 70 nt overhang 
substrate (Fig. 2C) recovered from wild type cells, including the 4 most common 
products (above dashed line) and 4 other representative examples (see also Table S1). 
The first 3 columns summarize the structures of the inferred intermediates. (C) For 
experiments described in Fig. 3A (using the 45 nt overhang) we report the fraction of 
products directed by the terminal 4 bp microhomology (shown in panel B), as 
determined by sequencing. Data shown are the mean +/- SEM, n=3. Statistical 
significance was assessed by two-way ANOVA (p values as above). (D) The extent 
each sized microhomology is enriched (bars right of Y axis) or depleted (bars left of Y 
axis) in recovered junctions, relative to their representation in the set of all possible 
deletion products. See also Figure S3, Table S1. 
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Figure 2.4: Pol q is a strand displacing polymerase 
 
(A) Schematic showing the possible Pol q repair fates and the impact of each fate on 
digestion with BamHI and subsequent PCR amplification. (B) qPCR quantification (top 
panel) and 6% PAGE gel analysis (bottom panel) of noted substrates, either treated as 
a mock sample or BamHI digested, followed by PCR amplification. 
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Figure 2.5: Proposed model of Pol q-mediated end joining 
 
Proposed mechanism of cellular Pol q activity including a i) search for microhomology, 
ii) removal of non-homologous tails, and iii) synthesis. 
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Figure 2.6: Effect of varied overhang length and polarity on end joining  
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Figure 2.6: Effect of varied overhang length and polarity on end joining 
 
(A) Substrates with 3’ single stranded DNA overhangs ranging from 4-70 nt were 
introduced into WT MEFs. Joining efficiency was quantified as described in Figure 2. 
Data are the mean +/- SEM, n=3. (B) Joined products from panel A were characterized 
by amplification of end joining products and polyacrylamide gel electrophoresis. 
Products of size consistent with joining after overhang clipping vs. joining with overhang 
retained are noted, and their relative abundance (determined after correction for size) 
noted below. (C) A substrate with head and tail 45 nt 5’ overhangs was introduced into 
the noted cell types and the efficiency (top panel) and character (bottom panel) of end 
joining were assessed as described in Figure 2. Data are the mean +/- SEM, n=3. 
Statistical significance assessed by one-way ANOVA with Bonferoni correction. (D) 
Electrophoretic mobility shift assay showing loading of Ku onto substrates containing a 
38 base pair duplex DNA blocked on one end with a biotin-Streptavidin moiety, and 
either a 4 nt or 70 nt 3’ ssDNA overhang.  
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Figure 2.7: Separation of function in Pol q and role of terminal microhomology 
 
(A) Domain structure of Pol q. Experiments performed in Figure 3 use Polq-/- MEFs 
expressing WT human Polq cDNAs, as well as Polq cDNAs with an ATPase defective 
mutation (K121M) or mutations that ablate polymerase activity (D2330A, Y2331A). (B) 
The 45 nt 3’ overhang substrate described in Fig. 2B was transfected into WT and Polq-
/- MEFs. A variant of this substrate with no ability to align either at the extreme 3’ termini, 
or the second most favored alignment (shown in the cartoon) was transfected in 
parallel; joining efficiency was assessed using overhang specific primers as described 
in Figure 3. Data are the mean +/- SEM, n=3. Statistical significance assessed one-way 
ANOVA with Bonferoni correction.  
 
A.
Helicase-like Polymerase
PolymeraseATPase Dead
*K121M
Helicase-like Pol Dead
*D2330A
*Y2331A
DNA Polymerase θ
0.0
0.5
1.0
1.5
WT Polq-/-
NS
Jo
in
in
g 
Ef
fic
ie
nc
y 
(R
el
at
iv
e 
to
 W
T 
45
 n
t)
45 nt
GCAG
45 nt
5’P
GCAG
5’P
B.
GCAG
CGTC5’P
5’P AGAT
TCTA5’P
5’PGC
AG
CG
CGTC
5’P
45 nt
Favored Embedded
Alignment
Terminal 
Alignment
45 nt
45 nt ΔMH
Favored Embedded
Alignment
Terminal 
Alignment
XX
45 nt
45 nt ΔMH
AGAG
5’P
45 nt
Wyatt, et al. Figure S3
	 37	
Extrachromosomal	Substrate:	Left	Caps		
4	nt	 5’P/AGTCTGAGATGGGTGCCACGACG	
10	nt	 5’P/AGTCTGAGATGGGTGTGAGAGTGATCTGC	
20	nt	 5’P/AGTCTGAGATGGGTGTGAGAGTGAAGATCCTCGATCTGC	
30	nt	 5’P/AGTCTGAGATGGGTGTGAGAGTGAAGATCCTCACCTTCGGACGATCTGC	
45	nt	 5’P/AGTCTGAGATGGGTGTGAGAGTGAAGATCCTCACCTTCGGAGTACTCCTTCTTTTGAGATCTGC	
70	nt	 5’P/AGTCTGAGATGGGTGTGAGAGTGAAGATCCTCACCTTCGGAGTACTCCTTCTTTTGACCATTGATACGATACTTCTCAGCCGAGATCTGC	
45	nt	DMH	
5’P/AGTCTGAGATGGGTGTGAGAGTGAAGATCCTCACCTTCGGAGTACTCCTTCTTTTGACT
AGAGA	
45	nt	5’	Overhang	 5’P/GCAGATCTCAAAAGAAGGAGTACTCCGAAGGTGAGGATCTTCACTCTCACACCCATCTCA	
Annealing	Strand	 5’P/CTCACACCCATCTCA	
5’	Biotin	Flap	 5’Biotin/TTTTTTTTTTTTTTTTTTTTCTCACACCCATCTCA	
Annealing	Strand	for	
5’	Overhang	
5’P/AGTCTGAGATGGGTGTGAG	
	
	
Extrachromosomal	Substrate:	Right	Caps		
4	nt	 5’P/TGACTATACAGCTAAGCCCACGACG	
10	nt	 5’P/TGACTATACAGCTAAGCGATGCTCGATGCAG	
20	nt	 5’P/TGACTATACAGCTAAGCGATGCTCTCACCGAGCGGATGCAG	
30	nt	 5’P/TGACTATACAGCTAAGCGATGCTCTCACCGAGCGTATCTGCTGTGATGCAG	
45	nt	 5’P/TGACTATACAGCTAAGCGATGCTCTCACCGAGCGTATCTGCTGTGTTGTGGATGAATTAGATGCAG	
70	nt	 5’P/TGACTATACAGCTAAGCGATGCTCTCACCGAGCGTATCTGCTGGGTTGTGGATGAATTACATATGCTGGGAGAACCAAGATTGGATGCAG	
45	nt	DMH	 5’P/TGACTATACAGCTAAGCGATGCTCTCACCGAGCGTATCTGCTGTGTTGTGGATGAATTAGATGCAG	
45	nt	5’	Overhang	 5’P/CTGCATCTAATTCATCCACAACACAGCAGATACGCTCGGTGAGAGCATCGCTTAGCTGTATA	
Annealing	Strand	 5’P/CATCGCTTAGCTGTATA	
5’	Biotin	Flap	 5’Biotin/TTTTTTTTTTTTTTTTTTTTCATCGCTTAGCTGTATA	
Annealing	Strand	for	
5’	Overhang	
5’P/TGACTATACAGCTAAGCGATG	
	
	
Primers/Probes	
Sub	Duplex	Fwd	 5’CTTACGTTTGATTTCCCTGACTATACAG	
Sub	Duplex	Rev	 5’GCAGGGTAGCCAGTCTGAGATG		
Sub	Overhang	Fwd	 5’TAAGCGATGCTCTCACCGAG		
Sub	Overhang	Rev	 5’GATGGGTGTGAGAGTGAAGATC		
Sub	Recovery	Fwd	 5’GGCACTCTCCAAGGCAAAGA		
Sub	Recovery	Rev	 5’ACATGTCTAGCCTATTCCCGGCTT		
	
sgRNA	Sequences	
Ku70	Exon	3	 5’TCTTACTGGTGTACACACTC		
	 	
Gel	Shift	Assay	Oligos	(Fig.	S2)	
Common	Duplex	I	 5’P/GTCACCCAAATCAAACGTAAG/TEGBiotin	
Common	Duplex	II	 5’Cy5/CTTACGTTTGATTTCCC	
4	nt	Overhang	I	 5’P/GTGGGCTTAGCTGTATA	
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4	nt	Overhang	II	 5’P/TGACTATACAGCTAAGCCCACGACG	
70	nt	Overhang	I	 5’P/CATCGCTTAGCTGTATA	
70	nt	Overhang	II	 5’P/TGACTATACAGCTAAGCGATGCTCTCACCGAGCGTATCTGCTGGGTTGTGGATGAATTA
CATATGCTGGGAGAACCAAGATTGGATGCAG	
	 	
Antibodies	
Ku70	 Abcam	ab3114	
FLAG	Tag	 Sigma	F1804	
Actin	 Sigma	A2066	
	
Plasmids	
FLAG-Cas9	 A	gift	of	Xingxu	Huang	(Addgene	plasmid	#	44758)	
sgRNA	Plasmid	 A	gift	of	Xingxu	Huang	(Addgene	plasmid	#	51133)	
pMAX-GFP	 Lonza	
 
 
Table 2.1: Reagents used during experiments. 
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45	nt	Overhang	
Left	Flap	 Right	Flap	 MH	 Frequency	
0	 0	 4	 0.560	
4	 2	 4	 0.301	
11	 3	 3	 0.013	
3	 12	 3	 0.012	
2	 4	 1	 0.011	
13	 34	 4	 0.005	
	
	
70	nt	Overhang	
Left	Flap	 Right	Flap	 MH	 Frequency	
9	 2	 4	 0.334	
0	 0	 4	 0.200	
22	 10	 4	 0.083	
16	 13	 5	 0.058	
4	 3	 3	 0.032	
11	 16	 3	 0.024	
13	 1	 2	 0.021	
6	 9	 2	 0.017	
19	 15	 2	 0.015	
3	 12	 2	 0.013	
21	 30	 3	 0.013	
52	 22	 6	 0.013	
10	 14	 3	 0.013	
18	 17	 2	 0.008	
18	 42	 4	 0.007	
2	 10	 2	 0.007	
9	 7	 1	 0.006	
12	 27	 3	 0.005	
17	 2	 3	 0.005	
9	 20	 2	 0.004	
0	 14	 2	 0.004	
10	 37	 4	 0.004	
47	 10	 4	 0.004	
25	 29	 3	 0.004	
18	 23	 1	 0.003	
 
 
Table 2.2: Inferred alignment structures and recovery frequencies for the most 
frequently recovered products for noted substrates. 
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CHAPTER 3: ROLE OF TMEJ IN CHROMOSOMAL DOUBLE STRAND BREAK 
REPAIR 
 
 
3.1 Introduction 
Repair of chromosome double strand breaks (DSBs) is essential for normal cell growth 
and resistance to exogenous break-inducing agents. At the organismal level DSB repair 
also protects against cancer, shapes the response to cancer therapy, and has specialized 
roles in germ cell and immune system development. Mammalian cells typically rely on 
two pathways for DSB repair: classically defined non-homologous end joining (NHEJ) and 
homologous recombination (HR). Resection, the excision of 5’ terminal strands of the 
broken ends to expose long 3’ ssDNA tails, is an essential intermediate in HR and helps 
channel DSBs to repair by this pathway67.  
A third DSB repair pathway, termed Alternative NHEJ or microhomology-mediated 
end joining (Alt-NHEJ/MMEJ), has also been described. Alt-NHEJ was initially defined as 
both independent of factors required for NHEJ and associated with deletions clustered at 
3 to 6 base pair (bp) sequence identities (“microhomologies”) in flanking DNA15,76. Such 
products also typically require factors that promote resection (e.g. CtIP and Mre11)126 
indicating that, like HR, Alt-NHEJ typically acts downstream of this step. 
Alt-NHEJ/MMEJ in metazoans has also been linked to activity of DNA polymerase 
theta (Pol q; encoded by Polq)107. By comparison, an ortholog for metazoan Pol q is 
missing in yeast126, where synthesis during MMEJ has instead been associated with the 
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combined activity of multiple polymerases80. Pol q is a 290kDa protein with a super family 
2 helicase-like domain in the N-terminal third, and a Family A DNA polymerase domain 
in the C-terminal third87. Both in vitro and cellular experiments indicate it promotes MMEJ 
by using one 3’ ssDNA overhang as a synthesis primer, after annealing this overhang to 
a second ssDNA overhang at a short tract of complementary sequence 107. Strikingly, Pol 
q is frequently over-expressed in HR-deficient cancers and overexpression is linked to 
poor prognosis89,110,127. Pol q can also be essential in the context of HR deficient cancer 
cell lines89,108 identifying it as a promising therapeutic target.  
The role of Pol q in cellular repair and the relationship between this pathway and 
canonical DSB repair pathways (NHEJ, HR) are still unclear. We investigated these 
questions through use of chromosomal assays and a panel of mouse embryo fibroblast 
lines (MEF) cell lines deficient in Polq, NHEJ (Ku70), and factors implicated in control of 
end resection and repair pathway choice (Mre11, 53BP1). Our results provide insight 
into how Pol q activity contributes to cellular DSB repair. We show that Pol q activity is 
essential when canonical repair pathways are impaired. We further identify an essential 
role for this enzyme in rescuing repair of DSBs in contexts where the ability to 
appropriately regulate end-resection has been compromised.  
 
3.2 Methods 
Cell lines  
Experiments varying Polq status employed SV-40 Large T antigen transformed MEFs 
recovered from mice where a Polq null allele was generated by conventional gene 
targeting and made isogenic by backcrossing in mice. Polq-/- MEFs were then 
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complemented by lentiviral delivery of cDNA coding wild type human Polq, a 
polymerase domain variant harboring D2330A and Y2331A mutations, or a helicase 
domain variant harboring a K121M mutation. Deficiency or complementation was 
assessed by RT-qPCR for mRNA expression relative to a housekeeping control 
(GAPDH).  
Variants of the above lines with frameshift mutations in Exon 3 of the Ku70 gene 
were made following transient expression of Cas9 and sgRNA, and complemented 
variants of these Ku70 deficient lines made with lentivirus expressing mouse Ku70. 
Ku70 deficiency or complementation was validated by western analysis and a functional 
assay for NHEJ activity. In Figures 3.1 and Figure 3.3 experiments, the relevant genes 
were mutagenized with lentivirus that co-expressed Cas9 and sgRNA.  
Chromosomal double strand break repair assays  
To assess chromosomal end joining, plasmids expressing Cas9 (5 ug) and Rosa26 
sgRNA (5 ug) were introduced into 2x106 cells by electroporation (Neon, Invitrogen) 
using a 1350 V, 30 ms pulse in a 100 μL chamber (Table 3.1). Cells were re-plated into 
DMEM without penicillin-streptomycin. Genomic DNA was purified at 6, 24, and 48 
hours post-transfection (QiaAMP kit, Qiagen) and products were characterized by 
polyacrylamide gel electrophoresis on a 6% gel and by amplicon sequencing of a 472 
bp region flanking the Cas9 cut site. 
To assess gene targeting through homologous recombination at the Rosa26 locus, 
plasmids expressing Cas9 (5 ug) and Rosa26 sgRNA (5 ug), and a homology donor 
(20ug) that destroys the Cas9 recognition site by integration of a non-endogenous ScaI 
restriction enzyme site were introduced into 2x106 cells by electroporation (Neon, 
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Invitrogen) using a 1350 V, 30 ms pulse in a 100 μL chamber. Cells were re-plated into 
DMEM without penicillin-streptomycin. Genomic DNA was purified 48 hours post-
transfection (QiaAMP kit, Qiagen). Homologous recombination was measured by PCR 
amplification of the target site and digestion with ScaI, followed by polyacrylamide gel 
electrophoresis on a 5% gel of the target site and quantification of relative band 
intensities (ImageStudio). Dependency on Rad51 was confirmed by transfection of 20 
nM control or Rad51 targeting siRNA pools prepared with RNAimax (Thermo). 
Depletion of Rad51 was confirmed by western blot.  
To assess translocation formation, plasmids expressing Cas9 (5 ug) and Rosa26 
sgRNA (5 ug), and a plasmid expressing H3f3b sgRNA (5 ug) were introduced into 
2x106 cells by electroporation (Neon, Invitrogen) using a 1350 V, 30 ms pulse in a 100 
μL chamber. Cells were re-plated into DMEM without penicillin-streptomycin. Genomic 
DNA was purified 48 hours post-transfection (QiaAMP kit, Qiagen). Translocation 
frequency was determined by digital droplet PCR (ddPCR) quantification. To detect 
translocations, 35 ng of genomic DNA was emulsified into ~20,000 independent oil-
based droplets in the presence of Taq man reagents and 2x Master Mix for probes 
(BioRad) using a QX100 Droplet Generator (BioRad). Parallel reactions and reagents 
were used to score translocations (Translocation Fwd/Rev/Probe) and number of 
genomes sampled (Genome Ctrl Fwd/Rev/Probe). Droplets were amplified for 40 
cycles, then read for fluorescence using a QX100 Droplet Reader (BioRad), and 
analyzed with Quantasoft ddPCR software. Parallel reactions were also chloroform 
extracted, and sequenced using standard methods.  
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Sequencing 
Template DNA for each sequencing library was from independent 
electroporations performed across three days. 2x104 input junction molecules were 
amplified using Phusion DNA polymerase (NEB) and PCR primers with 6 nt barcode 
sequences appended to their 5’ ends for 22 cycles (Table 3.1). 15.5 ng of amplified 
DNA from each library was pooled in groups of ~10 libraries, phosphorylated with T4 
PNK (NEB), treated with dATP and Klenow Exo – (NEB) to adenylate the 3’ termini. 
Adaptors for sequencing (Illumina) were then appended to the amplicons by ligation, 
and free adaptor removed by gel purification. Gel purified pooled libraries were 
subjected to a 10 cycle enrichment amplification with adaptor-specific primers and 
purified with Ampure XP beads (Agencourt, Beckman Coulter). Equal amounts of DNA 
from each pooled library set were combined and submitted for a 2x300 paired end 
sequencing run (MiSeq, Illumina), with a PhiX174 DNA spike. 
 After sequencing, reads of PhiX174 DNA were removed. Remaining reads were 
then trimmed for quality, paired ends were merged, and libraries were de-indexed using 
Genomics workbench v8.0 (CLC-Bio). Greater than 50,000 reads/replicate were 
typically recovered for each replicate; reads recovered less frequently than expected 
given the oversampling ratio (typically about 5) were discarded as likely products of 
error during sample processing. Characterization of substrate repair junctions was 
performed by alignment of reads to a reference junction, export in SAM format, and 
deconstruction of the CIGAR string in Excel (Microsoft) to yield parameters including 
flanking deletion, length of ssDNA tails generated, and microhomology content at the 
junction. Deletion maps were generated using the ggplot package in R-Studio. 
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Insertions >24 bp (Figure 3.2, Table 3.2) were mapped against the reference mouse 
genome with batch BLAST searches. 
 We additionally assessed the extent to which proportional sampling of the 
population was maintained under the experimental conditions by amplifying and 
sequencing a control library of four cloned junctions of varying fragment size where the 
input number of template molecules was comparable to cellular experiments. The mean 
frequency of recovery for each of the four products was 25.4% (+/- 2.8%), and thus not 
significantly different than expected assuming equal efficiency of recovery (25%).  
Cell cycle analysis 
S-phase cells were quantified by flow cytometry after cells were treated with 10 uM 
BrdU (Sigma) for 1 hour, fixed, washed with PBS, treated with 0.1 M HCl/0.5% Triton X-
100, and stained for both total DNA and incorporated BrdU.  
Chromosomal aberrations 
Chromosomal aberrations (breaks, fragments, and fusions) were counted after cells 
were treated with 50 ng/ml colcemid for 45 min, lysed, fixed, and stained with Giemsa 
(Gibco).  
Immunofluorescence 
Cells were irradiated with 1 Gy of gamma radiation and incubated for 6 hours, 
then washed, fixed, permeabilized, and stained to detect nuclear material (DAPI) and 
Rad51 foci. Images were acquired using a Pla-ApochroMAT, 63x /1.4 oil DIC objective 
lens (Zeiss Axio Imager 2, Duke University). Nuclei containing >10 foci were counted as 
positive, with 100 cells counted for each experiment. 
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Cell proliferation assays 
 To generate growth curves of the MEF panel described above, cells of each 
genotype were plated at 5x103 cells per well in 24 well dishes. Cells were allowed to 
recover from plating for 12 hours, then were trypsinized, and counted on a 
hemocytometer every 24 hours over a 5-day period. Proliferation was quantified relative 
to the number of cells present for each condition at 12 hours post-plating. 
 To assess colony forming ability, Cas9 and sgRNAs targeting either control 
genes, or genes of interest were delivered to MEF cells via lentiviral transduction of a 
construct co-expressing both CRISPR/Cas9 components. 48 hours post-transduction, 
cells were plated at low density into 10 cm plates containing 2 ug/ml puromycin to select 
for transduced cells. Plates were fixed and stained 10 days later with 6% glutaraldehyde 
and 0.5% crystal violet. Colonies of >100 cells were counted. 
Resection Assay 
 To measure the amount of resected DNA present at the chromosome 6 cut site 
we adapted a previously described assay for quantifying ssDNA in the genome by 
qPCR128. In short, PstI resection enzyme sites were chosen at intervals downstream (50 
bp and 400 bp) of the chromosome 6 cut site. 150 ng of genomic DNA was digested 
overnight with PstI in a 20 ul reaction volume and used as template for a Taq man 
qPCR flanking the restriction enzyme site. Single stranded DNA is insensitive to PstI 
digestion and % ssDNA is quantified based on qPCR results.  
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3.3 Results 
To better address the relationship between TMEJ and classically defined NHEJ we 
sought to make cell lines deficient in one or the other pathway, or both. We 
consequently employed CRISPR/Cas9 to generate variants of existing isogenic wild 
type and Polq-/- MEF lines107 that do not express significant Ku70 protein. These lines 
are deficient in NHEJ, and can be complemented by expression of introduced Ku70 
cDNA. Importantly, bi-allelic mutation of the Ku70 gene in Polq-/- cells was rare, and 
relative to the other cell types the isolated Polq-/-Ku70-/- cell line had both low colony 
forming efficiency and a severe proliferative defect, (Figure 3.1A). Combined loss of 
Ku70 and Pol q is also associated with a reduced fraction of cells in S phase and 
increased chromosome aberrations (Figure 3.7A, 3.7B). Expression of a Ku70 cDNA in 
this line was sufficient to correct the growth defect, confirming it could be attributed to 
combined loss of Ku70 and Pol q. To further address this issue we performed a 
reciprocal experiment, by mutagenizing Pol q in the context of cells already deficient in 
Ku70. Lentiviral infection of Ku70 deficient cells with 3 different constructs that target 
mutations to the Polq gene, but not 3 different control target sites, severely reduced 
both the frequency and size of colonies formed (Figure 3.1B). No significant differences 
in colony forming ability were observed when the same 6 viruses were introduced into 
wild type cells (Figure 3.7C). Deficiencies in Ku70 and Pol q thus have synergistic 
effects on cell growth and viability - the doubly deficient cells are “synthetic sick”.  
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TMEJ rescues chromosome break repair when canonical pathways are 
compromised 
We next addressed the relationship between TMEJ and canonical pathways (NHEJ, 
HR) in repair of a chromosome break by introducing a DSB with the Cas9 nuclease 
targeted to the Rosa26 locus in Chromosome 6 (Figure 3.2A). We then determined the 
effect of Pol q and Ku70 deficiencies on repair of this break by end joining (Figure 3.2, 
Figure 3.3) and HR (Figure 3.5), as well as the extent to which it is prone to participating 
in translocations with another Cas9-induced break (Figure 3.5). We confirmed all cell 
types expressed comparable amounts of Cas9 (Figure 3.8A), and assessed end joining 
by sequencing the region flanking the target site. As it is not possible to distinguish 
uncut chromosome from error free repair, we consider as definitive products of end 
joining only those sequences with insertions or deletions at the target site.  
The majority (75%) of products in wild type (WT) cells had short 1-5 bp deletions, 
and deficiency in Pol q had little impact on either the frequency or character of these 
products (Figure 3.2B, Figure 3.8B). This is consistent with a predominant role for NHEJ 
in repairing these breaks. By comparison, deletions that were both intermediate in size 
(between 5 and 50 bp) and associated with microhomologies were depleted in Pol q 
deficient cells (reduced 4 fold; Figure 3.2C). Expression of a WT Polq cDNA was 
sufficient to reverse this defect (Figure 3.8C), and the effect of Pol q on microhomology 
associated deletion was apparent for all microhomology lengths greater than 2 bp 
(Figure 3.8D).  
Deficiency in Ku70/NHEJ resulted in deletions that were both much larger and more 
frequently associated with microhomology (Figure 3.2B, 3.2C). These microhomology-
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associated deletions were again mostly dependent on Pol q (reduced 7 fold in Polq-/-
Ku70-/- cells), but the effect of Pol q was no longer limited to the subset of deletions 
ranging from 5-50 bp (Figure 3.2C). We additionally confirmed expression of a Ku70 
cDNA in both Ku70 deficient cells (Ku70-/-, Polq-/-Ku70-/-) was sufficient to return the 
frequency and pattern of microhomology associated deletions to that observed in the 
matched Ku70+/+ parent cell lines (Figure 3.8C). Comparison of end joining spectra over 
time also indicates that TMEJ is engaged much more rapidly in Ku deficient cells 
(Figure 3.8E). Therefore, relative to an NHEJ proficient background, TMEJ in Ku70 
deficient cells accounts for a much larger fraction of repair, is engaged faster, and its 
influence now extends to large deletions.  
Two classes of insertions had conspicuously distinct genetic requirements. Most 
insertions were short (1-4 bp) and generated during repair by NHEJ (reduced 7 fold in 
Ku70-/- cells; Table 3.2). In contrast, deficiency in Ku70 alone had the opposite effect on 
longer insertions (3 fold increase), and these longer insertions were dependent on Pol q 
(Figure 3.2D). To assess if these Pol q-dependent insertions were templated, we 
focused on the subset of insertions that were sufficiently large (>24 bp) to allow 
mapping to the mouse genome. Most of these insertions – 87% of those observed in 
Ku70-/- cells – could be mapped (i.e. were definitively templated) to sequence near the 
Cas9 target site in chromosome 6 (Table 3.2). A surprisingly high frequency (1.5X10-3 in 
Ku70-/- cells) of end joining products recovered had insertions that used template from 
other chromosomes (Table 3.2), and were derived from both genic and intergenic 
regions. Template switching events, both intra- and inter-chromosomal, were often 
complex (Figure 3.2E), with successive segments derived from template tracts 
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separated by 100s of base pairs, and 2-3 bp microhomologies often evident in the 
flanks of successive segments. In some cases successive segments were derived from 
nearby DNA but employed the opposite strand as template. Insertions mediated by Pol 
q are thus largely template-dependent, and provide striking evidence of the ability of this 
polymerase to promiscuously switch template. 
We show above that in Ku deficient cells TMEJ/ Pol q is both engaged more rapidly 
and accounts for a much greater fraction of repair. Since extrachromosomal 
experiments indicated Pol q acts only on pre-resected ends, we reasoned the synthetic 
effects of Pol q and Ku deficiency on proliferative capacity could reflect excessive end 
resection associated with Ku70 deficiency, and a central role for TMEJ in rescuing 
repair of these ends. In accord with this model, mutagenesis of the Mre11 gene, a factor 
implicated in end resection, had an impact on large deletion in Ku70-/- cells comparable 
to loss of Pol q (Figure 3.3A). Direct measurement of resected DNA surrounding the 
chromosome 6 break, quantified by PstI restriction endonuclease sensitivity, showed 
that resection is significantly increased in Ku70-deficienct cells, and that resection 
increases over time (Figure 3.4A). This increase in resection is fully ablated upon 
compound mutagenesis of the Ku70 and Mre11 genes (Figure 3.4B). This model also 
predicts there should be a genetic interaction between Polq and 53BP1, a factor that 
promotes NHEJ in part by antagonizing end resection59,129. Strikingly, lentiviral 
constructs engineered to mutate the 53BP1 gene, but not off-target controls, reduced 
both the frequency and size of colonies formed in a Pol q deficient background (Figure 
3.3B, Figure 3.9). By comparison, there was no difference comparing targeting vs. non-
targeting constructs in parallel experiments in wild type cells (Figure 3.9). Our results 
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thus identify a central role for TMEJ in repairing chromosome breaks when resection is 
excessive or mis-regulated.  
We next sought to address whether defects in TMEJ might influence the efficiency of 
repair by HR of the same break studied in the experiments described above (Figure 3.2 
and Figure 3.3A). We generated breaks at the Cas9 site in chromosome 6 as above, 
but now included an extrachromosomal homology donor with 6 bp substituted at the 
target site that both ablates Cas9 recognition and introduces a site for the restriction 
endonuclease ScaI (Figure 3.5A). Products of HR were thus scored as ScaI sensitive 
species in amplified products of the native chromosome flanking the Cas9 target; these 
were sensitive to depletion of Rad51 (Figure 3.10A) and dependent on both the 
presence of the homology donor and the initiating DSB (Figure 3.5B). We observed a 
frequency of HR in WT MEFs of 10%, and this is increased more than 2 fold in Ku70 
deficient cells (Figure 3.5C, Figure 3.10B). By comparison, deficiency in Pol q did not 
similarly result in increased HR. Indeed, loss of Pol q in cells deficient in Ku70, where 
TMEJ otherwise accounts for a large fraction of repair, led instead to a slight decrease 
in HR efficiency. We note loss of Pol q does increase a marker of an intermediate step 
in HR, ionizing radiation-induced Rad51 foci89,108, but this effect was again less than 
that attributable to deficiency in Ku70 (Figure 3.10C, 3.10D). We conclude NHEJ 
effectively competes with HR for repair of nuclease-induced breaks (in accord with 
previous work)130, but that TMEJ does not.  
Simultaneous breakage at two sites in the genome can lead to the joining of ends 
from different chromosomes, or translocation. We addressed the contribution of TMEJ 
to this process by again introducing breaks at the previously used Cas9 site in 
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chromosome 6, but now also introduced a second break at a site in chromosome 11 
(Figure 3.5D). Genomic DNA was then harvested and used as template in emulsion 
PCRs (ddPCRs) to assess the frequency of the t(6;11) der11 translocation product. In 
accord with previous work131, translocation frequency relative to WT cells was increased 
3 fold in Ku70 deficient cells (Figure 3.5E). However, deficiency in Pol q alone had no 
significant impact. Moreover, characterization of translocation products indicated that for 
each of the four cell types (WT, Polq-/-, Ku70-/-, and Polq-/-Ku70-/-), the frequency of 
junctions with microhomology was reduced relative to the products of intra-
chromosomal deletion (Table 3.3). TMEJ thus does not promote formation of 
translocations under the conditions used here. More significantly, the frequency of 
translocation was highest when cells were deficient in both Pol q and Ku70. TMEJ can 
thus protect against this class of chromosome rearrangement, though this effect was 
significant here only if cells are unable to efficiently repair breaks by NHEJ. 
 
3.4 Discussion 
Our results indicate that in cells, Pol q has a crucial role as a back up pathway to 
canonical double strand break repair mechanisms. We show deficiency in Pol q alone 
has at best minor effects on activities of other pathways (NHEJ and HR) in the repair of 
a Cas9-induced break (Figure 3.2, Figure 3.5). TMEJ thus does not typically compete 
with these pathways. However, TMEJ has a critical role when there is excessive 
resection, i.e. cells deficient in Ku70 or 53BP1 (Figure 3.1, Figure 3.2, Figure 3.3). We 
conclude Pol q/TMEJ is essential for repair of DSBs when either major DSB repair 
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pathway is compromised (Figure 3.6), and both protects against or promotes genome 
instability dependent on context (Figure 3.5 and discussed below). 
Role of TMEJ in double strand break repair 
What is the relationship between previously defined Alt-NHEJ/MMEJ and Pol q-
dependent repair/TMEJ? Microhomology associated deletions typically used to define 
Alt-NHEJ/MMEJ are severely depleted in both Pol q deficient contexts (i.e. Polq-/- and 
Polq-/-Ku70-/-), relative to their matched Polq proficient counterparts (Figure 3.2). 
Similarly, Alt-NHEJ has been defined as dependent on prior resection of ends, and we 
determined the effect of Pol q deficiency on microhomology associated deletions is 
comparable to deficiency in a factor required for end resection, Mre11 (Figure 3.3A). 
There is also little evidence for repair of pre-resected extrachromosomal substrates in 
cells deficient in both Pol q and Ku70 (Chapter 2, Figure 2.2). Taken together, our 
evidence indicates TMEJ accounts for the majority of events previously defined as 
MMEJ or Alt-NHEJ. Nevertheless, chromosomal end joining products still accumulate in 
Polq-/-Ku70-/- cells (Figure 3.2B). This may represent residual repair mediated by the 
remaining NHEJ components, or an as yet un-defined and largely microhomology-
independent alternative to the end joining pathways referenced so far (Alt-
NHEJ/MMEJ/TMEJ and NHEJ).  
In cells proficient in both NHEJ and HR, loss of Pol q significantly affects only a small 
fraction (<5%) of DSB repair (Figure 3.2C), consistent with mild phenotypes of cells and 
mice deficient in Pol q alone98. TMEJ is also associated only with deletions of 
intermediate size (5-50 bp) in this context. By comparison, TMEJ is engaged more 
rapidly, more often, and affects a wider range (5-250 bp) of deletions in cells deficient in 
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Ku70/NHEJ. Cell growth and viability are also severely impaired in cells deficient in both 
Pol q and Ku70 (Figure 3.1), or Pol q and 53BP1 (Figure 3.3); the latter factor is more 
specifically associated with attenuation of end resection than is Ku70. Our results are 
thus consistent with a central role for TMEJ when end structures are poor substrates for 
NHEJ, as well as in cells prone to excessive end resection (Figure 3.6).  
Homology-dependent repair of Cas9-induced breaks was stimulated more than two 
fold by loss of Ku70. In contrast, loss of Pol q had no significant effect on HR of the 
same break, even in a Ku70 deficient background. TMEJ is thus a less effective 
competitor than is NHEJ for repair of DSBs, at least when the DSBs are destined for 
successful repair. A similar lack of effect of Pol q deficiency on repair by HR is evident in 
C. elegans102. Pol q loss is nevertheless sufficient to stimulate IR-dependent Rad51 
foci89,108 (Figure 3.10C, 3.10D), which could reflect the accumulation of products of 
aborted HR that are no longer resolved by Pol q-dependent means. 
Previous work identified a key role for TMEJ in repair of chromosome breaks in 
homologous-recombination deficient cancer cell lines89,108. Here we find the events we 
can attribute to Pol q/TMEJ – deletions that are less than 50 bp and associated with 
flanking microhomologies >2 bp or insertions > 4 bp – is precisely equivalent to a 
mutational signature associated with those breast, ovarian, and pancreatic cancers that 
have mutations in BRCA1 and BRCA2 (COSMIC Signature 3)132.  
Strikingly, 53BP1 loss has opposite effects on cell viability when comparing cells 
deficient in Pol q vs. cells deficient in BRCA1; it impairs growth and viability in the 
former context (Figure 3.3B), but rescues it in the latter59,129. Of special note is the ability 
of 53BP1 loss to “protect” BRCA1 deficient cancers from therapies that employ 
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inhibitors of poly(ADP)ribose polymerase. Our data indicate Pol q/TMEJ activity will be 
essential in the context of this mechanism of therapy resistance. These results 
emphasize the critical importance of appropriately regulated end-resection, and further 
emphasizes the importance of Pol q/TMEJ as a therapeutic target. 
TMEJ and genome instability 
There is evidence that Pol q/TMEJ both suppresses and promotes DSB-induced 
chromosome rearrangement. Pol q was identified in a systematic screen for 
suppressors of spontaneous genome instability97, and it additionally suppresses 
translocations associated with immunoglobulin class switch recombination107. We report 
here that Pol q can also suppress translocations between a pair of Cas9-induced breaks 
targeted to different chromosomes, though a significant effect was limited to cells 
already deficient in NHEJ (Figure 3.5B). Moreover, the fraction of these translocation 
products associated with a TMEJ-like signature (e.g. microhomologies) was reduced 
relative to matched products of intra-chromosomal deletion for all four cell types.  
In contrast, a previous report assessing Cas9-induced translocations indicated these 
were promoted by Pol q, and Pol q was required in NHEJ deficient cells for fusion of 
chromosomes at de-protected telomeres108. Additionally, this and related studies133 
indicate translocation products are often enriched for TMEJ-associated signatures. 
Moreover, as also noted above, this signature is associated with deletions observed in 
hereditary breast cancer132. 
Results described here also suggest how Pol q/TMEJ could promote chromosome 
rearrangement. Analysis of intra-chromosomal deletions identified frequent “template-
switching” events; these insertions were assembled from multiple template segments, 
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sometimes from opposite strands, and often with 2-4 bp microhomologies associated 
with the flanks of successive segments. Importantly, promiscuity in template switching 
extended to surprisingly frequent switching to template tracts in other chromosomes 
(1.5x10-3 of total products in Ku70 deficient cells). We note our ability to recover 
examples of switching of template to another chromosome required a "switching back” 
of the repair process, such that the rejoined product remained intrachromosomal. It thus 
seems likely there is an undetected fraction of these events – perhaps even the majority 
– that never switch back, and contribute to chromosome aberrations similar to the 
microhomology-mediated break induced replication (MM-BIR) events described in yeast 
and mediated by Pol z and Rev1134.  
This varied contribution of Pol q/TMEJ to genome instability in mammalian cells may 
reflect differences in the origin of the chromosome break and cell type. Notably, 
evidence that TMEJ suppresses genome instability comes from analysis of populations 
of primary cells, and where the assessed chromosome aberrations arise from 
chromosome breakage that was spontaneous98 or naturally programmed107. The 
properly regulated use of TMEJ as a backup mechanism thus may protect against 
genome instability. However, as is apparent in hereditary breast cancer, defective DNA 
damage responses in transformed cell lines and cancers can result in excessive 
engagement of TMEJ and even an “addiction” to this pathway89,108,110,127. The ability of 
Pol q/TMEJ to promote genome instability may thus be acquired in parallel with the 
transition of its role from backup to essential. In sum, this work identifies Pol q as a 
critical factor in the survival and evolution of cancers deficient in canonical repair 
pathways, as well as a promising target for the treatment of these cancers. 
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Figure 3.1: Effect of end joining deficiencies on cell proliferation 
 
(A) The noted cell types were seeded at 5x103 cells/well in 24 well dishes, then counted 
12 hours after plating and every 24 hours afterwards. Data shown are the mean +/- 
SEM, n=3. (B) Ku70-/- cells were infected with lentivirus containing Cas9 and either 
control guides or guides targeting sites in regions coding for mouse Pol q, seeded into 
10 cm plates, and stained after 10 days (right panel). Colonies of more than 100 cells 
were counted from triplicate experiments (left panel); Data shown are the mean +/- 
SEM, n=3. Statistical significance was assessed by ANOVA with Bonferoni correction 
for multiple comparisons. ***p<0.001. 
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Figure 3.2: Effect of end joining deficiencies on repair of Cas9-induced 
chromosome breaks 
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Figure 3.2: Effect of end joining deficiencies on repair of Cas9-induced 
chromosome breaks 
 
(A) Cas9 and guide RNA specific to a chromosome 6 target were expressed in the 
noted cell types, and products of end joining characterized by target site amplification 
and sequencing. (B) Bars denote extent of deleted DNA for each end joining product 
relative to the Cas9 target site, and are shaded according to the extent of 
microhomology as noted in the legend. The height of each bar on the Y axis defines the 
proportion of each product in a set of 20,000 estimated input molecules, and is 
averaged from 3 experiments for each of WT (top left), Polq-/- (top right), Ku70-/-, (bottom 
left), and Polq-/-Ku70-/- cells (bottom right). (C) The percentage of all end joining 
products with microhomology >2 bp and deletion (Δ) within the noted size ranges. Data 
shown are the mean +/- SEM, n=3. Statistical significance was assessed by two-way 
ANOVA with Bonferoni correction (results for the 5-50 bp category shown). *p<0.05, 
****p<0.0001. (D) The percentage of all end joining products with insertion >4 bp 
recovered from MEF lines described above. Data shown are the mean +/- SEM, n=3. 
Statistical significance was assessed by one-way ANOVA with Bonferoni correction (p 
values as above). (E) Structure of selected Pol q mediated insertions. Successive 
segments denote template switching, with opposing arrows identifying use of opposite 
strands. The lengths of microhomologies in flanks of successive segments are in 
parentheses. Black segments, from chromosome 6; red segments, from other 
chromosomes.  
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Figure 3.3: Effect of aberrant end resection on repair and viability  
 
(A) Template DNA from the experiment described in Fig. 4 (left panel), or from Ku70-/- 
cells infected with lentivirus containing Cas9 and either a pool of control guides or 
guides targeting Mre11 at amino acids 572 or 603 respectively (right panel), was 
amplified and characterized by electrophoresis. (B) Polq-/- cells were infected with 
lentivirus containing Cas9 and a pool of either control guides or guides targeting 53BP1. 
Colony forming ability was assessed as in Fig. 1B. Data shown are the mean +/- SEM, 
n=3. Statistical significance was assessed by unpaired T-test. ***p<0.001. See also 
Figure S5. 
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Figure 3.4: Direct measurement of resected DSBs  
 
(A) Template DNA from the experiment described in Fig. 4 (left panel), or from Ku70-/- 
cells infected with lentivirus containing Cas9 and either a pool of control guides or 
guides targeting Mre11 at amino acids 572 or 603 respectively (right panel), was 
amplified and characterized by electrophoresis. (B) Polq-/- cells were infected with 
lentivirus containing Cas9 and a pool of either control guides or guides targeting 53BP1. 
Colony forming ability was assessed as in Fig. 1B. Data shown are the mean +/- SEM, 
n=3. Statistical significance was assessed by unpaired T-test. ***p<0.001. See also 
Figure S5. 
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Figure 3.5: Effect of end joining deficiencies on repair of chromosomal breaks by 
homologous recombination and translocation 
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Figure 3.5: Effect of end joining deficiencies on repair of chromosomal breaks by 
homologous recombination and translocation 
 
(A, B) Homologous recombination was assessed by introduction of Cas9, guide RNA, 
and a plasmid homology donor that introduces a ScaI recognition site at the site of 
breakage in chromosome 6 into noted cell types. DNA was harvested 48 hours later, 
amplified, and digested with ScaI followed by electrophoresis. (C) The mean fraction of 
the chromosome 6 target site that acquired sensitivity to ScaI. Data shown are the 
mean +/- SEM, n=3. Statistical significance assessed by one-way ANOVA with 
Bonferoni correction. NS =not significant, ***p<0.001, ****p<0.0001. (D) Cas9 and guide 
RNAs targeting chromosome 6 and chromosome 11 were expressed in the noted cell 
types. Genomic DNA was isolated after 48 hours and used as template for parallel 
emulsion PCRs (ddPCR) specific for the t(6,11) der11 translocation product and an 
input genome control. (E) Mean frequency of der11 translocations is determined by the 
number of translocations over the number of input genomes; Data shown are the mean 
+/- SEM, n=3, with >4x104 genomes assessed/experiment. Statistical significance was 
assessed by one-way ANOVA with Bonferoni correction (p values as above).  
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Figure 3.6: Mechanism and cellular roles of Pol q-mediated end joining 
 
Suggested contexts for engagement of Pol q mediated end joining, and proposed 
mechanism including a i) search for microhomology, ii) removal of non-homologous 
tails, and iii) synthesis. 
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Figure 3.7: Characterization of Ku70/Pol q synthetic sickness 
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Figure 3.7: Characterization of Ku70/Pol q synthetic sickness 
(A) BrdU incorporation was assessed in the noted cell types by flow cytometry. Data are 
the mean +/- SEM, n=3. Statistical significance assessed by one-way ANOVA with 
Bonferoni correction. (B) Total chromosome aberrations (chromatid breakage, 
fragments/small chromatin, and chromosome exchanges/fusions) were scored on 
metaphase spreads of the noted cell types. Data are the mean +/- SEM, n=3. Statistical 
significance assessed by one-way ANOVA with Bonferoni correction. (C) Wild type cells 
were infected with lentivirus containing Cas9 and either control guides or guides 
targeting sites in regions coding for mouse Pol q, seeded into 10 cm plates, and stained 
after 10 days (right panel). Colonies of more than 100 cells were counted from triplicate 
experiments (left panel); Data shown are the mean +/- SEM, n=3. 
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Figure 3.8: Supplemental characterization of effects of end joining deficiencies on 
repair of Cas9-induced chromosome breaks 
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Figure 3.8: Supplemental characterization of effects of end joining deficiencies on 
repair of Cas9-induced chromosome breaks 
 
(A) Representative Western blot showing Cas9 expression 24 hours post transfection in 
noted cell types. Noted below are the mean levels of Cas9 expressed (normalized to 
correct for loading differences using the Actin control) in replicate transfections, relative 
to WT MEFs. (B) Box plots describe the inter-quartile range of deletions observed in the 
noted cell types. Whiskers describe deletions in the 10th to 90th percentile range.(C) The 
percentage of all end joining products with microhomology >2 nt and associated with 
deletion either between 5 and 50 bp or >50 bp recovered from noted cell types. Data 
are the mean +/- SEM, n=3. (D) The extent each sized microhomology is enriched (bars 
right of Y axis) or depleted (bars left of Y axis) is expressed as the fraction of products 
recovered from WT cells over the fraction of products recovered from Polq-/- cells for 
each category. (E) The percentage of all end joining products with microhomology >2 nt 
recovered from sequencing of DNA flanking the chromosome 6 Cas9 target site over 6, 
24, and 48 hrs in the noted cell types. Data are the mean +/- SEM, n=3. 
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Figure 3.9: Effect of 53BP1 mutagenesis in WT cells 
 
(A) WT cells were infected with lentivirus containing Cas9 and either control guides or 
guides targeting sites in regions coding for mouse 53BP1, seeded into 10 cm plates, 
and stained after 10 days (right panel). Colonies of more than 100 cells were counted 
from triplicate experiments (left panel); Data shown are the mean +/- SEM, n=3. 
Statistical significance assessed by one-way ANOVA with Bonferoni correction. (B) 
Polq-/- cells were infected with lentivirus containing Cas9 and either control guides or 
guides targeting sites in regions coding for mouse 53BP1, seeded into 10 cm plates, 
and stained after 10 days (right panel). Colonies of more than 100 cells were counted 
from triplicate experiments (left panel); Data shown are the mean +/- SEM, n=3. 
Statistical significance assessed by one-way ANOVA with Bonferoni correction.  
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Figure 3.10: Effect of Rad51 depletion and Ku deficiency on homologous 
recombination 
 
(A) Homologous recombination in WT MEFs transfected with either control or Rad51 
siRNA pools, quantified as described in Figure 6. Data are the mean +/- SEM, n=3. 
Statistical significance assessed by one-way ANOVA with Bonferoni correction. (B) 
Homologous recombination in the noted cell types, quantified as described in Figure 6. 
Error bars represent the standard error of the mean of three independent 
electroporations. Data are the mean +/- SEM, n=3. Statistical significance assessed 
one-way ANOVA with Bonferoni correction. (C) Noted cell types were treated with 1 Gy 
of gamma radiation and co-stained for Rad51 foci (red) and nuclear material (DAPI, 
blue). (D) Nuclei from experiment in panel C containing >10 Rad51 foci were counted as 
positive, with 100 cells scored for duplicate experiments. Data are the mean +/- SEM, 
n=3. Statistical significance assessed by two-way ANOVA with Bonferoni correction 
(results for the +IR category are shown).  
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Primers/Probes	
Chromosome	6	Fwd	 5’TCAGTTGGGCTGTTTTGGAG		
Chromosome	6	Rev	 5’GGCGGATCACAAGCAATAAT		
HR	Fwd	 5’AGAATGCAGTGTTGAGGCC		
HR	Rev	 5’AGAAAACTGGCCCTTGCCATT		
Translocation	Fwd	 5’AGCCACAGTGCTCACATCAC		
Translocation	Rev	 5’TCCCAAAGTCGCTCTGAGTT		
Translocation	Probe	 5’/56-FAM/TCAGTAAGG/ZEN/GAGCTGCAGTGGAGTA/3IABkFQ/	
Genome	Ctrl	Fwd	 5’GGGAAGTGAGAGAGAAACTGAAG		
Genome	Ctrl	Rev	 5’AAACCTGAGCCAGACTTTCC	
Genome	Ctrl	Probe	 5’/5HEX/TCAGCAAAG/ZEN/ACCGCGGAAAGATCT/3IABkFQ/	
	
sgRNA	Sequences	
Ctrl-1	 5’ACTCCAGTCTTTCTAGAAGA	(Fig.	1)	
Ctrl-2	 5’CGCCGTGCACTGGTTCCGAA	(Fig.	1)	
Ctrl-3	 5’GGCATCATTATTCAAATCAG	(Fig.	1)	
Polq-2285	 5’CAGTTCAAGCTGAGAGTAGT	(Fig.	1)	
Polq-6	 5’CGCCGTTTCCTACTCCGGCG	(Fig.	1)	
Polq-16	 5’TCCCGAGAACGTGTCGGAGC	(Fig.	1)	
Chr	6	(Rosa	26)	 5’ACTCCAGTCTTTCTAGAAGA	(Fig.	4-6)	
Chr	11	(H3f3b)	 5’GTTGGCTCGCCGGATACGGG	(Fig.	6)	
Mre11-572	 5’GGCCGAGGCCGAGGGCGAAG	(Fig.	5)	
Mre11-603	 5’TGGAGATCACTACTCGAGGC	(Fig.	5)	
53BP1-211		 5’TTCTAGCCCGCTATCTGATG	(Fig.	5,	S5)	
53BP1-246	 5’GTTACAGTACAGCCCGGTAA	(Fig.	5,	S5)	
53BP1-1520	 5’ACAAGCTGCTCTTTGATGAT	(Fig.	S5)	
	
Antibodies	
FLAG	Tag	 Sigma	F1804	
53BP1	 Bethyl	Laboratories	A300-272A	
MRE11	 Gift	from	John	Petrini	
Actin	 Sigma	A2066	
Rad51		 Novus	nb100-48	
	 	
SiRNA	 	
siCtrl	Pool	 Dharmacon	D-001206-13-05	
SiRad51	Pool	 Dharmacon	M-062730-01-0005	
	 	
Plasmids	
FLAG-Cas9	 A	gift	of	Xingxu	Huang	(Addgene	plasmid	#	44758)	
sgRNA	Plasmid	 A	gift	of	Xingxu	Huang	(Addgene	plasmid	#	51133)	
Lenti-CRISPRv2	 A	gift	from	Feng	Zhang	(Addgene	plasmid	#	52961)	
Rosa	26	Homology	
Donor	
605	bp	of	identity	to	sequence	upstream	of	the	Rosa26	target,	a	central	segment	
sufficient	to	destroy	recognition	by	the	Rosa26	targeting	guide	and	create	a	ScaI	
restriction	enzyme	site,	followed	by	537	bp	of	identity	to	sequence	downstream	of	
the	Rosa	26	cut	site,	cloned	into	PCR2.1		
 
Table 3.1: Reagents used during experiments. 
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Genotype	 1-4	bp	Short	
	(SEM)	
>4	bp	Long	
(SEM)	
>24	bp	Very	long	“mappable”	(SEM)	
	 Ch	6	 Other		 Not	mapped	
WT	 0.28	(0.02)	 5.5(0.6)x10-3	 1.1(.02)x10-3	 6.1(2.0)x10-5	 4.3(0.3)x10-4	
Polq-/-	 0.21	(0.01)	 6.4(2.0)x10-4	 6.9(3.5)x10-5	 0	 2.0(0.8)x10-4	
Ku70-/-	 0.04	(0.002)	 2.0(0.04)x10-2	 5.3(0.9)x10-3	 1.5(0.4)x10-3	 1.0(0.7)x10-3	
Polq-/-Ku70-
/-	
0.06	(0.01)	 5.6(0.6)x10-4	 0(0)	 1.1(0.8)x10-4	 0	
 
Table 3.2: Frequency of insertions observed in end joining products.  
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	 Frequency	of	products	with	>2	bp	microhomology	
Genotype	 Ch6	Intrachromosomal		 t(6;11)	translocation	
WT	 (0.162)	 1/24	(0.042)		
Polq-/-	 (0.124)	 0/22	(0)	
Ku70-/-	 (0.399)	 5/31	(0.161)	
Polq-/-	Ku70-/-	 (0.166)	 2/21	(0.096)	
 
 
Table 3.3: Frequency of products with >2 bp of microhomology.  
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CHAPTER 4: DISCUSSION 
  
 DNA double strand breaks are a structurally diverse and highly genotoxic class of 
damage that can result in cell death and promote disease on the organismal level. 
Canonical DSB repair pathways, NHEJ and HR, have evolved to combat these lesions 
and restore genome integrity. When considering the types and extent of damage that 
can be associated with DSBs, it stands to reason that some breaks will not be 
accessible to either canonical repair pathway for a variety of reasons. Associated base 
damage (e.g. abasic sites or occluding protein adducts), or the nature of the break (e.g. 
“one-ended” breaks from replication fork collapse) may prevent loading of or repair by 
the NHEJ machinery. Similarly, cell cycle restrictions or failures during HR may result in 
free, resected DSB end structures that cannot be metabolized by NHEJ. For such 
contexts, cells must rely on an alternative means to repair damage. 
 My work, presented in this dissertation, shows that DNA Polymerase q defines a 
third DSB repair pathway, termed TMEJ, that has an important role in protecting 
genome stability. In Chapter 2, I define the biological substrates and cellular mechanism 
of TMEJ by means of an extrachromosomal end joining assay and characterization of 
repair junctions. I then present in Chapter 3, data defining the role of TMEJ during 
chromosomal repair. I show here that TMEJ is essential for cell survival when canonical 
pathways are impaired or otherwise unable to resolve damage, and when DNA end 
resection is misregulated. This chapter also reveals a role for Pol q in the mutagenic 
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signatures observed in hereditary breast cancer. Thus, my dissertation reveals TMEJ to 
be a flexible, efficient, semi-conservative DSB repair pathway that can have major 
impacts on organismal health.  
 
4.1 Identification of biological substrates 
 Prior work has suggested that Pol q promotes microhomology-mediated repair of 
DSBs in D.melanogaster and C. elegans, but has not directly identified the biological 
intermediates or mechanisms that lead to these resolutions99,106,107. My work, using an 
extrachromosomal end joining assay, shows that in mammalian cells, Pol q directly 
utilizes 3’ resected end structures as substrate for a DNA synthesis reaction and repair. 
Out of 17 mammalian DNA polymerases, this synthesis activity is unique to Pol q. This 
finding is consistent with previously published work, where a purified polymerase 
domain fragment of Pol q was capable of joining DNA substrates via a terminal 
microhomology alignment135. However, contrary to this in vitro work, where Pol q activity 
was limited to synthesis of less than 15 bp, I have found that in cells, Pol q efficiently 
mediates the repair of substrates requiring at least 70 nt of DNA synthesis. I also show 
that in cells, Pol q does not dissociate at the ssDNA to duplex transition and is capable 
of bypassing 5’ abasic site damage by displacing the top strand of an annealed duplex 
and continuing synthesis for at least an additional 15 nt. Taken together, these results 
show that in cells, Pol q mediates a “long-patch” DSB repair process that is far more 
processive and efficient than has been previously described. 
 It is important to note however, that TMEJ is not the only option for joining resected 
substrates. When the extent of resection is 45 nt or less, nucleolytic removal of the 3’ 
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overhang and joining by NHEJ is the dominant fate. The nuclease responsible for 
trimming these long 3’ tails is currently unknown, but the clipping reaction appears to be 
tied to the NHEJ complex, with Artemis being a strong nuclease candidate. As resection 
extends past 45 nt, genetic requirements switch and end joining predominantly relies on 
Pol q. This is explained by the inability of Ku to load on longer 3’ ssDNA tails, perhaps 
as a result of intramolecular secondary structures formed on the long overhangs.  
 Extending the observation that impaired Ku loading effectively shunts substrate to 
TMEJ, I also show that Pol q has a unique role in the joining of forked substrates that 
are mimetic of the one-ended DSB structures expected following replication fork 
collapse. These structures completely ablate the ability of Ku to load onto the broken 
end and therefore cannot be repaired by NHEJ. The unique ability of Pol q to resolve 
these structures provides evidence that TMEJ is a crucial pathway in high replication 
stress environments. This hypothesis is corroborated by the observations that Pol q is 
most highly expressed in rapidly dividing germ cells, and is essential for early embryonic 
development and germ cell maintenance in some model organisms88,102,136. 
 
 4.2 Microhomology search mechanism 
 DNA end resection initiates with an MRN-dependent generation of ~20-50 nt of 
ssDNA and can extend to several kilobases in length45,46,128. End resection exposes 
patches of microhomology between the two DNA strands that are used to align strands 
and prime synthesis by Pol q; yet it was not known how much complementarity is 
needed to prime synthesis or how microhomologies are found during cellular repair. 
Using high throughput sequencing of repair junctions from both extrachromosomal 
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substrate and CRISPR/Cas9 derived chromosomal DSBs, I show here that Pol q-
mediated joins are enriched over chance only when there is an alignment of greater 
than 2 bp. Chromosomally, Pol q will use microhomologies as large as 7 nucleotides, 
though the chance of such tandem repeats of homology decreases exponentially with 
size, making the practical definition of microhomology in the 3-6 bp range. 
 My work also defines a role for the N-terminal helicase-like domain of Pol q in an 
active search for microhomology alignments. Cells harboring an inactivating mutation in 
the Walker-A motif of the ATPase domain (K121M) have a reduced ability to utilize 
internally embedded microhomologies, and instead strongly favor alignment by a 
microhomology at the absolute 3’ termini. This result is consistent with recent structural 
studies of the helicase-like domain which proposed a model where 3’ DNA tails are 
pulled through a central channel and slid past each other90. This structure also revealed 
several new motifs, including an “RAR” motif that might directly interact with the 3’ 
hydroxyl of the resected end. In light of these results, a full mechanistic exploration of 
the helicase-like domain and microhomology search engine should be undertaken. 
 Both extrachromosomal and chromosomal repair junctions recovered from wild type 
cells show that this microhomology search is restricted to the terminal ~25 nt of each 3’ 
end. Employing an active search mechanism for alignments > 2 bp within this 2x25 nt 
space allows for TMEJ to repair virtually any pair of DSB ends, regardless of sequence 
context, in manner that limits deletion size to no more than 50 bp. Thus, the TMEJ 
mechanism protects the genome from the toxic effects of DSBs and limits 
catastrophically large deletion, though in a manner that is likely to be substantially more 
mutagenic than NHEJ or HR.  
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4.3 Other TMEJ Factors 
 Pol q is an essential core factor for TMEJ/Alt-EJ/MMEJ, yet it is likely only one of a 
host of associated factors. My work indicates that Mre11 is also essential for TMEJ, with 
cells depleted of Mre11 via CRISPR/Cas9 mutagenesis acting as Pol q knockouts 
during chromosomal end joining. This result is likely through an upstream role in end 
resection and the generation of Pol q substrate. While these two factors begin to 
delineate the steps of the pathway, there is otherwise little information known about 
associated factors. Previous studies have suggested that both Ligase I and III 
participate in Alt-EJ137. This is consistent with my observations that repair by TMEJ 
involves strand displacement synthesis; ultimately this synthesis activity will result in a 
nick structure that must sealed by either Ligase I or III. The following questions raised 
by my work should be explored in further detail in an effort to identify other components 
of the pathway: what nucleases are associated with TMEJ, and does Pol q associate 
with processivity factors during cellular repair?  
 My results show that Pol q effectively uses embedded microhomology alignments 
that will generate 3’ nonhomologous tails once the two ssDNA strands are aligned; 
however Pol q is incapable of synthesizing from a mispaired nonhomologous tail, with 
efficiency reduced over 1000-fold on such a substrate. This indicates that a nuclease 
must resolve at least one of the tails prior to synthesis. For TMEJ to act efficiently, this 
nuclease activity must be tightly coupled with Pol q. Candidates for this nuclease 
include Mre11 and XPF:ERCC1. In particular, the XPF ortholog Rad10 has previously 
described roles MMEJ in S. cerevisiae, while in a mammalian model, loss of ERCC1 
hypersensitized Ku80-deficient cells to IR exposure138,139. It is also of interest to identify 
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the nuclease responsible for resolving the 5’ flap generated by strand displacement 
synthesis. FEN-1 is a strong candidate for this, in line with its known role in trimming 5’ 
flaps during Okazaki fragment resolution140. 
 With respect to processivity factors, I have shown that Pol q mediates the repair of 
much larger tracts of DNA than was previously suggested by in vitro studies135. It is 
possible that Pol q associates with a factor such as PCNA or Rev1 during cellular repair, 
though there is no obvious PIP motif in the primary sequence of the protein. Another 
possibility is that Pol q acts in a manner similar to translesion synthesis polymerases. In 
such a model, Pol q would synthesize enough from a microhomology alignment that a 
stable primer was made for a replicative polymerase to switch on and complete repair. 
 
 
4.4 Relationships between TMEJ and canonical double strand break repair 
pathways 
 
 Microhomology-mediated end joining was initially discovered in systems that were 
deficient in NHEJ11-15,76. These studies, coupled with the relatively mild radiosensitivity 
of Pol q-deficient cells 107, point to a role for TMEJ as a backup repair pathway. I have 
extended these observations to show that under normal cellular conditions, Pol q acts 
on approximately 5% of Cas9-induced double strand breaks; by comparison > 75% of 
such breaks are engaged by NHEJ. However, when cells are made deficient in NHEJ, 
TMEJ accounts for the majority of DSB repair. Further, cells that are doubly deficient in 
Ku70 and Pol q have severe proliferation defects, including a reduced fraction of cells 
that actively replicate DNA and increased spontaneous chromosomal fusions. Taken 
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together, my results provide evidence that TMEJ is a minor, yet essential back up repair 
pathway to NHEJ.  
 In contrast, the relationship between HR and TMEJ is not well defined. The two 
pathways both utilize the resected end intermediate as substrate, yet it is not clear if 
there is an active competition for resected ends. My results indicate that TMEJ does not 
impact levels of cellular HR, when using a donor construct that has 500 bp of homology 
flanking the left and right sides of the DSB (for a total of 1 kb of homology). However, 
continuing experiments in our lab suggest there may be a mild competition for substrate 
when length of homologous donor, and thus extent of resection, is decreased to 250 bp 
on each side (for a total of 500 bp of homology). This is consistent with reports of a mild 
stimulation of HR in Pol q-deficient cells when measuring recombination of a relatively 
small (500 bp) GFP reporter89. It is plausible that when end resection is shorter-range or 
slow, Pol q may have preferential access to ends. If true, this might be explained by a 
reduced access of RPA – a factor that promotes repair by HR, yet suppresses MMEJ141 
– to more minimally resected ends. Further exploring the kinetics of resection will be 
essential to understanding the interplay between these two pathways.  
 Additional studies are also needed to assess whether loss of Pol q is synthetic lethal 
with loss of HR factors in the same manner that it is with NHEJ. My work suggests that 
the mechanistic basis for synthetic lethality upon combined deficiency in TMEJ and 
NHEJ is that an excess of resected DSBs resulting from the loss of Ku70 or 53BP1 fail 
to be resolved. Deficiency in 53BP1 in particular leads to resection in G1 phase of the 
cell cycle, where HR is not able to act61. This hypothesis is supported by an increase in 
Rad51 foci in Polq-/- cells, presented here and by others89,108. Combined with the 
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observation that loss of Pol q does not impact levels of successful HR, the increased 
number of foci suggests that these are free resected ends, bound by recombinase, but 
not productively involved in repair. In a similar manner, loss of later-stage HR factors 
such as BRCA2, Rad54, or Holliday junction resolvases may lead to an accumulation of 
resected ends that is also toxic in Pol q-deficient cells. 
 
4.5 Polymerase q and genome stability 
 It is clear that under normal cellular conditions, the properly regulated use of TMEJ 
as a backup repair pathway protects genome integrity and cell viability, though the 
repair mechanism is inherently mutagenic. TMEJ limits potentially catastrophic deletion 
and provides an outlet for repairing potentially toxic double strand breaks. Pol q also 
plays a role in protecting against major chromosomal rearrangement, though its role in 
protecting against translocations is only revealed when cells are also deficient in NHEJ. 
I show here that compound loss of Pol q in Ku70-/- cells results in a 4-fold increase in 
translocations driven by tandem Cas9-induced DSBs on different chromosomes.  
 There are however, aspects of TMEJ that have the potential to be deleterious even 
under normal conditions. A rare class of TMEJ products that occur during chromosomal 
break repair involve large insertions at the repair junction that are templated from other 
chromosomes. Pol q appears to jump between chromosomes, priming successive 
segments of synthesis from microhomologies. These pseudo-translocation products are 
structurally similar to microhomology-mediated break induced replication (MM-BIR) 
events that occur in S. cerevisiae. While these products are generally rare (1.5x10-3 in 
Ku70-/- cells), I was only able to quantify those products that returned to the site of the 
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original DSB and were thus amplified and sequenced. If a larger fraction of products 
jump chromosomes and do not return, it may represent a potent mechanism for loss of 
heterozygosity. 
 
4.6 Polymerase q as a therapeutic target 
 One of the central findings of my research is that Pol q is a strong candidate for 
therapy in the treatment of hereditary breast cancers; especially those tumors which are 
resistant to PARPi therapy. This is supported by data showing that the chromosomal 
mutation signature of Pol q (microhomology >2 bp, centered at long deletions or 
insertions) is identical to the somatic mutation signature seen in BRCA1/2-deficient 
hereditary breast cancers, (COSMIC signature 3132). This is consistent with previous 
studies indicating that Pol q overexpression is associated with poor prognosis breast 
cancer, and that Pol q suppression may reduce tumor volume and increase survival of 
HR-deficient tumors89. Strengthening this argument, I also show here that loss of Pol q 
leads to synthetic lethality with loss of 53BP1. This anti-resection factor rescues growth 
and viability of BRCA1-deficient hereditary breast cancers, and protects the tumors from 
PARPi therapy59,129. My results suggest that Pol q will be essential in this mode of 
therapy resistance and will be a potent target for the treatment of such cancers. 
Development of small molecule drugs either targeting Pol q directly, or exploiting Pol q 
activity has already begun. A recent study presents that size-expanded benzo-
nucleotide analogs are incorporated exclusively by Pol q and that they act as DNA 
chain-terminators upon incorporation135. 
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4.7 Concluding Remarks 
 The work discussed within this thesis expands the current understanding of 
mammalian DSB repair, with direct consequences for the advancement of human 
health. My work and that of others defines the biological substrates, mechanism, 
context, and therapeutic potential of a novel DSB repair pathway mediated by DNA 
Polymerase q. This work also provides a roadmap for the mutational processes 
associated with DSB repair and contributes to the advancement of the burgeoning field 
of directed DNA editing technologies. As our knowledge of Pol q-directed DNA repair 
continues to expand it is becoming evident that TMEJ has broad implications beyond 
those of a simple back up repair pathway. 
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